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Abstract 
The effect of nanoparticles (NPs) of photoactive zinc and titanium oxides on innate 
immunity is unknown, despite the advent of new transparent sunscreens containing 
these nanomaterials. This is particularly important as tissue resident immune cells in 
the skin are the first point of contact where sunscreen NPs can be actively sequestered 
by cells. In preparing sunscreen formulations, NPs are also being coated with various 
surfactants – affecting their solubility, bioavailability and dermal penetration, which 
may also alter their potential immune effects. Widespread use of such materials in 
sunscreens is crucial to public health practices to reduce skin cancer in Australia, so 
their safety needs to be investigated.  Therefore, in this project I investigated the 
effect that these NPs have on the function of cellular elements of the innate immune 
system, including monocytes, macrophages, and Langerhans cells (LCs). Specific 
emphasis was placed on the role of intracellular zinc ions, reactive oxygen species 
(ROS), and altered immune functions following exposure to these NPs.  
 
Although zinc oxide (ZnO) NPs are widely used in sunscreens, the relationship 
between ROS generation, zinc ion release and the cytotoxicity caused by these 
particles, is not clearly understood. The first part of this project explored whether 
these factors could be accurately quantified and related. This study demonstrated a 
strong correlation between ZnO NP-induced cytotoxicity and free intracellular zinc 
concentration (R²=0.945) in human immune cells, indicating a requirement for NP 
dissolution to precede cytotoxicity. While direct exposure to ZnO NPs was found to 
induce cytotoxicity at relatively high concentrations, indirect exposure (via dialysis) 
was not cytotoxic, even at extremely high concentrations – highlighting a requirement 
 xix 
 
for NP-to-cell contact. The elevated ROS levels present in NP-exposed cells also 
correlated to both cytotoxicity and intracellular free zinc. Although the addition of 
antioxidants (ascorbate or α-tocopherol) was able to reduce ROS, cytotoxicity to ZnO 
NPs was unaffected – this suggested that ROS may be, in part, a result of cytotoxicity 
rather than solely as a causal factor for cytotoxicity. This study highlights both the 
requirement and role of the intracellular dissolution of zinc nanomaterials in eliciting 
a cytotoxic response. Therefore, modification of NP uptake and their intracellular 
solubility are key components in modulating the bioactivity of ZnO NPs. 
 
The second part of this project compared the ROS generation by UVA and sunscreen 
NPs in human immune cells. Although it is known that ROS generation occurs in 
cells exposed to ZnO and TiO2 NPs, it is unknown to what extent this ROS generation 
is altered with UVA co-exposure, which is more relevant to actual sunscreen usage. 
Furthermore, ZnO and TiO2 NPs in sunscreens themselves attenuate the oxidative 
damage to cells and tissues from free radicals induced by UVA irradiation. In order to 
determine the relative hazard potential of UVA co-exposure with nanosunscreen NPs, 
ROS generation was investigated in human THP-1 monocyte immune cells co-
exposed to UVA and NPs. Whilst the applied UVA dose (6.7 J/cm
2
) did not affect the 
viability of THP-1 monocytes, it induced significant ROS production in these cells. 
However, co-exposure to UVA and NPs generated the same or less ROS than with 
UVA alone, with the exception of the highly photocatalytic anatase form of TiO2, 
which significantly increased ROS levels. This study indicates that ROS generation 
from nanosunscreens is, in most cases, an insignificant contributor to the overall 
hazard associated with oxidative stress from UVA exposure itself. 
 
 xx 
 
In the third part of this project, the effect of ZnO NPs on the function of LCs was 
investigated, as these dendritic cells are present in the epidermis and constitute the 
first immunological barrier against NPs. This study found that ZnO NPs can 
simultaneously cause pro-inflammatory and anti-inflammatory effects in these antigen 
presenting cells. In addition, ZnO NPs altered the release of bioactive molecules 
(cytokines) from immune cells, suppressed antigen processing and presentation, and 
stimulated lymphocyte proliferation. This study indicates that ZnO NPs may modulate 
antigen presentation processes that can lead to allergic reactions. 
 
In conclusion, sunscreen ZnO and TiO2 NPs are well tolerated by skin immune cells, 
with ZnO only causing cytotoxicity at very high concentrations. Also, ZnO NPs 
possess immunomodulatory effects that provide further evidence of the mode of 
action in the therapeutic topical use of zinc. 
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Chapter 1. Introduction and Literature Review 
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1.1 Nanoparticles and Nanotechnology 
Nanotechnology is a fast growing field that has the potential to offer significant advances to 
society. Currently, nanotechnology is widely used in our daily life, such as nanoparticle-
based cosmetics, nano-emissive displays, nanofabric clothes, nanoparticle-lined refrigerators, 
and so on. It is estimated that nanotechnology will become a $1 trillion market by 2015 (Nel 
et al., 2006).  
 
1.1.1 Nanotechnology 
Nanotechnology is a technological development at the length scale of between approximately 
1 - 100 nanometers (nm), following the definition used by the National Nanotechnology 
Initiative (NNI) in the USA (NNI, 2013). NPs are often defined as particles having all 
dimensions that are between 1-100 nm (ISO, 2010).  
 
Materials at the nano-scale can show very different properties compared to the same material 
at larger scales. For example, gold which is normally chemically inert, can serve as a catalyst 
of oxidation reactions at the nano-scale (Goodman, 2008). Actually, NPs are not new to us 
and have been around for a long time. For instance, some NPs are naturally-occurring 
biological structures like viruses, or chemical by-products, such as those formed in ashes 
from volcanoes and fires. Other NPs come from man-made processes, such as welding fumes 
and car exhausts. It is, however, engineered NPs, which are deliberately manufactured to a 
specific size, shape and structure that have attracted the interest of scientific and industrial 
research. These engineered NPs are relatively new and have potential applications across a 
range of industries. It should also be noted that larger engineered materials often contain 
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incidental NPs. For example, nanosized ZnO NPs are found in the manufacture of bulk ZnO 
material using standard procedures.  
 
1.1.2 NPs in cosmetics and personal care products 
NPs have been used in almost every type of cosmetics and personal care products on the 
market, including deodorant, soap, toothpaste, shampoo, hair conditioner, sunscreen, anti-
wrinkle cream, moisturizer, foundation, face powder, lipstick, blush, eye shadow, nail polish, 
perfume and after-shave lotion (FoE, 2006). For example, due to the strong antibacterial 
property of nanosilver, it has been formulated into soap. Nanosized silica is also used in skin 
cream products. It is also reported that nanoencapsulation techniques are employed in 
perfumes for time-controlled and prolonged release of scents (Paget et al., 2006). 
 
The use of nano-sized metal oxides such as titanium dioxide (TiO2) and zinc oxide (ZnO) in 
sunscreens are two of the largest uses of NPs in cosmetics and personal care products. As 
TiO2 and ZnO are very efficient in filtering harmful ultraviolet (UV) light, these two 
materials are widely-formulated as UV filters in sunscreens and other personal care products. 
Micron-sized TiO2 and ZnO are white, and when used in sunscreens will appear as a thick 
white paste on the skin. However, when formulated at the nano-scale, these materials become 
transparent while still retaining their UV-filtering capability. Therefore, most TiO2 and ZnO 
sunscreens that are transparent (and not white) are indicative of the presence of nano-scale 
material (Figure 1.1). 
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Figure 1.1: Visual comparison of the skin application of sunscreen containing either bulk 
(right) or nano-sized (left) metal oxide particles. [Adapted from 
http://www.nanoandme.org/images/cosmetics_surfer.jpg] 
 
1.2 Nanosafety issues 
The novel properties of NPs have made nanotechnology applications very popular today. 
Although nanotechnology benefits society and the economy, increased exposure to NPs of 
workers and consumers may have the potential to cause adverse health effects. Current 
guidelines regard NPs as generalized hazardous chemicals, which means their deposition and 
use may have an impact on the environment and on humans. It is reported that exposures to 
certain NPs have been associated with many adverse health effects, such as pulmonary 
inflammation (Shvedova et al., 2005, 2008 & 2009; Rossi et al., 2010), genotoxicity 
(Lindberg et al., 2009), carcinogenicity (Takagi et al., 2008; Sakamoto et al., 2009) and 
circulatory effects (Nurkiewicz et al., 2004; Nurkiewicz et al., 2006). Rossi et al. reported 
that inhalational exposure to silica-coated TiO2 NPs induces pulmonary neutrophilia in mice 
(Rossi et al., 2010). Similar airway exposure studies with single-walled carbon nanotubes 
have shown pulmonary inflammatory in mice (Shvedova et al., 2005, 2008 & 2009). It was 
found that carbon nanotubes and graphite nanofibres can induce DNA damage and 
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micronuclei in human bronchial epithelial cells (Lindberg et al., 2009). It is also reported that 
multi-walled carbon nanotubes can induce mesothelioma in mice (Takagi et al., 2008, 
Sakamoto et al., 2009). However, it should be noted that not all NP types are biologically 
hazardous, and even for one NP type that demonstrates a cytotoxic response, there is a 
threshold dose for such cytotoxicity.  
 
Materials that are considered safe to use at larger particle scales may be not necessarily being 
as safe at the nano-scale. The novel physicochemical properties of NPs also raise concerns 
about potential negative effects on biological systems. However, very little is known about 
the risks of exposure to NPs. The research field of nanosafety has lagged far behind the 
advancement of nanotechnology due to several experimental challenges and issues faced 
when designing appropriate studies involving the toxicological assessment of NPs (Dhawan 
et al., 2009). One of the most important challenges of nanosafety research is the diverse 
physicochemical properties of NPs, including different particle sizes, surface chemistry and 
coating, solubility, shapes, and aggregation. So even the same NP material, with or without a 
surface coating, may lead to potentially different nanotoxicological outcomes. Safe Work 
Australia (Jackson, et al., 2010) has outlined the difficulty in monitoring NPs as they can 
form unpredictable structures in different solutions, which may alter their toxicological 
profiles. This is why at the present state, a case-by-case approach continues to be important to 
nanosafety research (Kisin et al., 2007; Zhu et al., 2007; Colognato et al., 2008; Karlsson et 
al., 2008; Muller et al., 2008; Pacurari et al., 2008). 
 
1.2.1 Physicochemical properties of NPs 
The physicochemical properties of NPs are very important to their bioactivity, and should be 
considered when talking about nanosafety issues. The unusual physicochemical properties of 
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NPs are attributable to the numerous particle characteristics stated above (Nel et al., 2006). 
NPs with different physicochemical characteristics may have different biological effects, 
which in turn can result in different cytotoxicity endpoints and profiles.  
 
Size and surface area are important characteristics of NPs. The number of atoms on the 
particle surface determines the reactivity of the material. As NPs decrease in size, their 
relative surface area increases, with an increasing proportion of the atoms displayed on the 
surface. For example, in a 30 nm particle, about 10% of its atoms are displayed on the surface, 
and as the particle size decreases to 10 and 3 nm, the percentage of atoms displayed on the 
surface increases to 20% and 50% respectively (Figure 1.2) (Oberdorster et al., 2005). Such 
surface atoms have elongated electron orbitals, resulting in the increased reactivity of 
nanomaterials. Secondly, size shrinkage of a material may also bring together discontinuous 
crystal planes and disrupt the electronic configuration of the material, which can result in 
altered electronic properties (Donaldson and Tran, 2002; Oberdorster et al., 2005). For 
example, electron capture can turn dioxygen (O2) interacting with the NP surface into 
superoxide radicals (O2
.-
), which may potentially increase oxidative stress in biological 
systems exposed to such NPs. 
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Figure 1.2: Relationship between diminishing particle size and the increase in the percentage 
of surface molecules. [Adapted from (Oberdorster et al., 2005)] 
 
Particle shape is also a very important physicochemical property of NPs. Sometimes even for 
the same material, alteration of the NP shape will result in different properties. For example, 
TiO2 NPs that are widely-used in sunscreens as a UV filter have two common crystalline 
shapes, anatase and rutile; the latter is less photocatalytic and therefore more desirable for use 
in sunscreens (Tran and Salmon, 2011).  
 
Other physicochemical properties such as surface coatings, solubility and aggregation will 
also affect the potential toxicity of NPs. For example, ZnO and TiO2 are two NPs with very 
different solubilities in aqueous systems; ZnO NPs have a much higher water solubility than 
TiO2 NPs. It is therefore possible that in certain systems, dissolved Zn
2+
contributes more to 
the cytotoxic properties of ZnO NPs than the particulate form itself (Xia et al., 2008). Surface 
coatings and aggregation of NPs may also lead to different biological effects, with the 
possibility of either negating or amplifying the nano-scale size effects. For example, the 
dispersants used for surface modification of NPs can affect many particulate properties – e.g. 
reactive surface area or particle-membrane interactions.  
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1.2.2 Different routes of exposure to NPs 
There are 3 main routes of exposure to NPs, like any other chemical, i.e. inhalation, oral and 
dermal exposure (Figure 1.3). Inhalation of airborne NPs, such as exhaust fumes, may be 
deposited in the respiratory tract and also enter the blood stream and translocate to other 
organs (Semmler-Behnke et al., 2008; Furuyama et al., 2009). Some NPs are used in food as 
food colorants, preservatives, and so on. Ingestion of these NPs may travel to other organ 
systems, such as the liver, brain, and heart (Oberdorster et al., 2005). In addition to the 
general physiological pH of 7.4, various organ systems can also exhibit different pH 
environments, including acidic environments that NPs such as ZnO would not survive. This 
again emphasises the concept that “all NPs are not the same”.  
 
Dermal exposure to NPs occurs when applying NP-containing cosmetics and personal care 
products on the skin. These NPs are usually metal oxides, and there is much evidence 
showing that these NPs do not penetrate beyond the stratum corneum of healthy skin (Elder 
et al., 2009; Sadrieh et al., 2010; Therapeutic Goods Administration, 2013). However, 
Gulson and coworkers found that very small amounts of Zn ions from sunscreens containing 
ZnO in bulk or NP form can enter the body (Gulson et al. 2010). Also, in a “worst case” 
scenario such as wound or UV-burned skin, it is highly possible that the NPs in the 
sunscreens may penetrate the epidermis and encounter immune cells. This project will focus 
on the safety of these metal oxides formulated in sunscreens and so, following the worst case 
scenario, human immune cells directly exposed to sunscreen NPs were investigated in this 
project. It should be noted that the immune responses measured in this study are also 
applicable to the potential immune effects from inhalational exposure to such NPs. 
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Figure 1.3: Potential routes of exposure to NPs. 
 
1.2.3 Approaches for toxicity assessment of NPs 
Several lines of investigations have been reported to measure the safety parameters of NPs. In 
general, the risk assessment for NPs can include evaluation of data from both in vitro and in 
vivo approaches (Table 1.1).  
 
1.2.3.1 In vitro assays 
The primary endpoint of interest for in vitro toxicology is cytotoxicity. In the in vitro assays, 
cytotoxicity is usually assessed by a decrease the viability of different cell types after 
exposure to NPs. These approaches include the trypan blue exclusion assay, tetrazolium dye-
based (MTT and MTS) assays, and the neutral red assay (Wang et al., 2007; Vevers and Jha, 
2008; Feltis et al., 2012). In addition to cytotoxicity, other common in vitro toxicological 
endpoints for nanotoxicology include: oxidative stress and reactive oxygen species (ROS) 
generation; genotoxicity; mode of cell death; intra- and intercellular signalling; and so on. 
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Table 1.1: Examples of the approaches for toxicity assessment of NPs. 
 Nanoparticle Cell types/ subjects 
Toxicity assay/ 
study 
Citation 
In vitro 
SiO2 NP 
WIL2-NS human 
lymphoblastoid cells 
MTT assay; 
trypan blue 
staining. 
(Wang et al., 
2007) 
ZnO NP 
THP-1 Human acute 
monocytic leukaemia 
cell line  
MTS assay 
(Feltis, et al., 
2012) 
TiO2 NP RTG-2 fish cells Neutral red assay 
(Vevers and 
Jha, 2008) 
CdTe QDs,  
Au NP 
NG108-15 murine 
neuroblastoma cells 
and HepG2 human 
hepatocellular 
carcinoma cells 
High-content 
screening assay 
(Jan et al., 
2008) 
In vivo 
TiO2 NP 
Male rats (Fischer 
344) 
Subchronic 
inhalation study 
(Oberdorster 
et al., 1994) 
Carbon NP Human subjects 
Subchronic 
inhalation study 
(Nemmar et 
al., 2002) 
Single-walled 
carbon 
nanotubes 
Male mice (B6C3F1, 
2 months old) 
Intratracheal 
Instillation study 
(Lam et al., 
2004) 
ZnO NP Human subjects 
Direct dermal 
exposure study 
(Gulson et al., 
2010) 
 
The choice of cell type for such in vitro assays is determined by the target organ/cell under 
investigation, the assay procedure and requirements, or the specific endpoints selected. As 
discussed before, there are different routes of exposure to NPs, so the appropriate cell type 
selected for a nanotoxicology study should match the route of exposure or target organ of 
specific interest to the test NPs. Epithelial cells are good candidate cells as they are the first 
contact barrier for NPs in all exposure routes. For the inhalation exposure route, human 
bronchial epithelial cells, such as A549 or BEAS-2B cell lines, are good cell candidates for 
screening cell responses in inhalation-related in vitro studies. For the dermal exposure route, 
primary keratinocytes harvested from human donors or immortalised keratinocyte cell lines, 
such as HaCaT cells, are frequently used. Thus, in vitro assays usually employ immortalised 
cell lines or primary cells. Immortalised cell lines are commonly used because their responses 
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are highly reproducible and they are easy to handle and culture compared to primary cells. 
However, some important cellular processes of primary cells may be altered or lost as a result 
of immortalisation, and this aspect must be taken into account when interpreting findings 
from such in vitro studies. 
 
Jan and coworkers (Jan et al., 2008) demonstrated the use of a high-content screening assay 
(HCA) as a universal tool to probe the cytotoxicity of NPs, specifically cadmium telluride 
quantum dots (CdTe QDs) and gold NPs (Au NPs). They proposed that the cellular 
morphology of neurons is suitable for automated HCA screening. They found that the CdTe 
QDs induced primarily an apoptotic response in a time- and dose-dependent manner, and also 
produced different toxicological profiles and responses in undifferentiated and differentiated 
neural cells. In contrast, the Au NPs were found to inhibit the proliferation and intracellular 
calcium release of HepG2 cells. In another study, Shaw et al. reported the development of in 
vitro assays that correlated with in vivo activity (Shaw et al., 2008). They assessed NP effects 
in a multidimensional manner, using multiple cell types and assays that reflect different 
aspects of cellular physiology. Hierarchical clustering of this data identified nanomaterials 
with similar patterns of biological activity across a broad sampling of cellular contexts. A 
subset of NPs was then tested in mice, and they found that NPs with similar activity profiles 
in vitro exerted similar effects on monocyte number following in vivo exposure. A 
shortcoming of the study is that the selected NPs were still very similar in nature, suggesting 
that their approach was efficient in characterizing similar NPs, but has not been validated as 
being suitable for different forms of nanomaterials. 
 
 
 
 12 
 
1.2.3.2 In vivo assays 
Rodents such as rats or mice are usually employed for in vivo toxicity studies of NPs. 
However, there are many issues and difficulties surrounding the design of appropriate in vivo 
dose ranges, reproducible NP sample preparation, and uniform repeated dosing of 
monodisperse NPs or their agglomerates, especially for inhalational studies. Human subjects 
have even been studied in such assays, with this data being the most valued according to the 
standard “weight of evidence” approach to evaluating findings in toxicological studies. 
 
1.2.3.2.1 Subchronic inhalation assay 
Oberdörster and coworkers reported a subchronic inhalation experiment on male Fischer 344 
rats (Oberdorster et al., 1994). Their study used whole body exposure of the rats to either 20 
or 200 nm TiO2 with similar concentrations, for 6 hours per day, 5 days per week for 12 
weeks. Control animals were sham-exposed to filtered air. Upon aerosolisation, both TiO2 
particle types formed agglomerates with mass median aerodynamic diameters of 0.71 µm (20 
nm) and 0.78 µm (200 nm), which were almost the same aerodynamic diameters for both 
TiO2 particulates, so the compartmental deposition in the respiratory tract of the animals was 
expected to be very similar. Rats were killed and sampled at 29 and 64 weeks after cessation 
of exposure. It was found that the 20 nm particles caused a persistently higher inflammatory 
reaction in rat lungs compared to the 200 nm particles. The authors concluded that the greater 
pulmonary effects of the TiO2 smaller-size particles were related to their larger specific 
surface area. 
 
Nemmar and coworkers reported on an inhalation study for the risk assessment of carbon 
particles in human subjects (Nemmar et al., 2002). In this study, they utilized a technique 
called ‘Technegas’, which is commonly used in diagnostic nuclear medicine for measuring 
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the distribution of ventilation (Rizzo-Padoin et al., 2001). The Technegas consisted of an 
aerosol suspension of 
99m
Tc-labeled ultrafine (<100 nm) carbon particles. The 5 healthy male 
volunteers participating this study inhaled approximately 100 MBq of Technegas in 3-5 
breaths via a mouthpiece. Immediately afterwards, their body images were acquired and 
blood samples were collected at different time points after the inhalation and measured the 
radioactivity. Substantial radioactivity in the liver and other areas of the body was seen in the 
gamma camera images, while radioactivity was also detected in blood. The authors concluded 
that the inhaled ultrafine 
99m
Tc-carbon particles, which are quite similar to actual air pollution 
particles, diffused rapidly into the systemic circulation. This study provided very valuable 
information about the behaviour of ultrafine particles inhaled by humans. 
 
1.2.3.2.2 Intratracheal instillation assay 
Lam et al. investigated the toxicity of single-walled carbon nanotubes by intratracheal 
instillation of mice (Lam et al., 2004). In this study, male mice (B6C3F1, 2 months old) were 
intratracheally instilled with 0.1 or 0.5 mg of carbon nanotubes (1 nm in diameter and several 
microns long), and killed 7 or 90 days after this single treatment for histopathological study 
of the lungs. Mouse serum was used as a vehicle control, while carbon black was the negative 
control and quartz the positive control. This study showed that carbon nanotubes induced 
dose dependent epithelioid granulomas and, in some cases, interstitial inflammation in 
animals after 7 days. These lesions persisted and were more pronounced after 90 days. The 
lungs of carbon black-treated mice were normal, while those treated with high-dose quartz 
revealed mild inflammation. Altogether, these results demonstrated that carbon nanotubes are 
much more toxic than carbon black and quartz if they reach the lungs, and are considered to 
present a serious health hazard following inhalational exposure. 
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1.2.3.2.3 Direct dermal exposure 
Gulson and coworkers (Gulson et al., 2010) conducted a hallmark study involving 17 
participants to trace the absorption or penetration of Zn from ZnO NPs in sunscreen applied 
to healthy human skin under conditions of normal use. In this study, they used an enriched 
rare stable isotope of Zn (Zn
68
) and formulated it into sunscreens (in the nano or bulk ZnO 
form), to measure the levels present in the blood and urine after exposure. The subjects had 
these sunscreen formulations applied to their backs twice daily for 5 days while doing typical 
beach activities. Unfortunately the single-label design of this study was unable to determine 
specifically whether ZnO NPs had penetrated the skin. The important findings from this study 
was that there was no difference seen between the trace levels of Zn
68
 in bulk or NP 
formulations in the blood samples of the male participants. However, the NP group had 
higher levels than bulk group in female participants, although the reason for this is unclear 
and may be due to some of the female subjects having better hydrated or thinner skin, which 
may make it easier for the formulations to penetrate through the skin. Although this 
difference was seen, the amount of sunscreen Zn present in blood samples was 1/1000
th
 of 
usual total blood Zn
2+
 concentrations. What’s more, this study also showed that the Zn 
persisted in the body for some days after the sunscreen was washed off, which could be 
important for zinc homeostasis and bioaccumulation. 
 
1.2.4 Toxicity assessment of sunscreen NPs 
In this project, the NPs of main interest are the metal oxide NPs used in sunscreen 
formulations, such as ZnO and TiO2. These NPs are currently used for their broad spectrum 
UV protection in sunscreens and personal care products.  
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1.2.4.1 Toxicity assessment of ZnO NPs 
Compared to TiO2, ZnO is theorised to have a lower toxicity potential, as it is a partially 
water soluble oxide of an essential metal that can be excreted by the body. However, the 
solubility of ZnO NPs to release Zn
2+
 is one major concern for ZnO toxicity. In addition, in 
low pH environments such as sweat, stomach fluid, and the lysosomes and endosomes inside 
cells, the rate of Zn
2+
 release from ZnO NPs would become faster, which would make ZnO 
more cytotoxic in these environments. It was found by Sasidharan and coworkers that ZnO 
nanocrystals in the acidic cancer microenvironment are more cytotoxic than in the nearly 
neutral pH of normal physiological environments, which is mainly due to the faster 
dissolution of ZnO at acidic pH (Sasidharan et al., 2011). In addition, Xia and coworkers 
reduced the dissolution of ZnO by iron-doping and, in turn, reduced the cytotoxicity of ZnO 
(Xia et al., 2011).  
 
ROS also play an important role in the cytotoxicity of ZnO NPs. Many literature reports have 
shown enhanced ROS generation in ZnO exposed cells. Xia and coworkers demonstrated that 
mitochondria superoxide levels were elevated in a mouse immune cell line and human lung 
epithelial cells exposed to 13 nm ZnO NPs (Xia et al., 2008). Also, a study by Applerot and 
coworkers suggested that the antibacterial effect of ZnO NPs is related to increased ROS-
mediated cell injury (Applerot et al., 2009). Although, elevated ROS correlates with the 
cytotoxicity profile of ZnO NPs, this does not necessarily mean that there is also a causative 
relationship between ROS and the cytotoxicity of ZnO NPs (Shen et al., 2013). 
 
One of the very few reports looking into toxicity induced by ZnO NPs after oral dosing of 
mice has shown that exposure to the extremely high dose of 1 g/kg caused considerable 
changes in blood coagulation, and biochemical and haematological parameters, as a result of 
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damage to the liver, spleen, pancreas, kidney, bone and heart (Wang et al., 2006; 2008). 
Changes in immune parameters seen in these animals included an increased neutrophil 
migration to the stomach, splenic corpuscle enlargement and infiltration of chronic 
inflammatory cells into the pancreas (Wang et al., 2006; 2008). While this data looks at a less 
likely route of significant exposure to ZnO NPs, it can be theorised that systemic effects will 
be similar if there is a sufficiently high exposure via the inhalation route, or at sites where the 
dermal layer is broken. 
 
1.2.4.2 Toxicity assessment of TiO2 NPs 
Unlike ZnO NPs, TiO2 are insoluble in biological systems. These NPs have previously been 
considered inert due to their bulk counterpart being used as a negative control in previous 
particulate in vitro studies (Luoto et al., 1997; Kilgour et al., 2000). In vitro studies 
comparing the cytotoxicity of ZnO and TiO2 NPs showed much lower cytotoxicity of TiO2 
NPs (11 nm) compared with ZnO NPs (13 nm) in both mouse immune cell line and human 
lung epithelial cells (Xia et al., 2008). In the doses below 10 ± 2 mg/m
3
 for airway exposure, 
TiO2 NPs are not toxic to mice (Rossi et al., 2010). However, TiO2 NPs (5 nm) at high dose (> 
50 mg/kg) are found to cause toxicity following abdominal injection (Liu et al., 2009). This 
study found that nano-anatase TiO2 in high doses caused serious damage to the liver, kidney, 
and myocardium of mice and disturbed the homeostasis of blood sugar and lipids in mice.  
 
Also different from ZnO, TiO2 has different crystalline shapes, with the most common forms 
being anatase and rutile. The anatase crystalline phase is far more photoactive than the rutile 
form, and can cause increased oxidation in the presence of light sources such as ultraviolet 
light (Bickley et al., 1991). Therefore, studies were designed to assess if ultrafine TiO2 
particles with similar hydrodynamic diameters, but different crystal phases, had differing 
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biological effects. The data from these experiments confirmed that anatase was significantly 
more cytotoxic and pro-inflammatory in the fibroblasts, macrophages and pulmonary systems 
of rats (Sayes et al., 2006; Warheit et al., 2007). 
1.3 Human Immune System 
The human immune system protects against harmful pathogens, especially those that can be 
recognized as antigens. Pathogens can be viruses, bacteria, and fungi. Substances can also 
interact with the immune system, be recognised as antigens and removed from the body 
and/or cause immune responses – these include toxins, chemicals, and foreign particles (such 
as NPs) (Cherukuri et al., 2004). Immune system disorders can result in disease and even 
death. Tissue resident immune cells are a first point of contact where NPs can be actively 
sequestered by cells. It should also be noted that the immune system has an important role in 
clearing debris (i.e. NPs). Phagocytic immune cells also act as concentrators of NPs 
(Cherukuri et al., 2004; Unfried et al., 2007; Zolnik et al., 2010) – this is important as it is 
expected that immune cells would therefore be exposed to higher doses of NPs than other cell 
types. Therefore investigation into the effect of NPs on the function of immune cells is a very 
important aspect of nanosafety research.  
 
1.3.1 Immune response 
The immune response is the mechanism by which the body recognizes and defends itself 
against potentially harmful antigens. There are two types of immune response: innate and 
adaptive. The innate immune response, which is also called the nonspecific immune response, 
is the defense system that is active from birth without prior exposure to specific antigens 
(Male et al., 2013). It provides protection from all antigens in general, though the quality of 
this protection can vary greatly. The adaptive immune response, which is also called the 
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specific immune response, is immunity that develops with exposure to specific antigens and 
offers protection from many pathogens that are able to evade innate immunity (Male et al., 
2013). The most important part of adaptive immunity is that it has memory, enabling it to 
respond strongly on a second exposure. 
 
1.3.1.1 Inflammation 
Inflammation is a protective process the body uses to remove harmful stimuli and to initiate 
the healing process. It is one of the first responses of the immune system to infection (Kawai 
and Akira, 2006). Inflammation can be classified as being either acute or chronic in nature. 
Acute inflammation is the initial response of the organism to injurious stimuli; it is helpful to 
the body by removing pathogens, debris and dead tissue to assist the healing process. 
Conversely, chronic inflammation is harmful as it is persistent inflammation that is 
unresolved. Inflammation is very important to NP bioactivity, as even without direct toxicity, 
there can be significant problems if an NP causes inflammation, or worse, if this 
inflammation becomes chronic. The other possibility of NP exposure is an 
immunosuppressive effect (Brinker, 2012), if the NPs interfere with immune function, which 
may increase susceptibility to diseases. 
 
There are two general types of inflammatory mediators, exogenous and endogenous 
mediators. Exogenous inflammatory mediators are not produced by the immune system, but 
are produced by external stimuli, such as bacterial products and toxins (Campos et al., 2004). 
Endogenous inflammatory mediators are produced from the immune system itself, such as 
leukocytes when they reach the site of inflammation. These inflammatory mediators can also 
be derived from molecules that are normally present in the plasma in an inactive form 
(Webster and Galley, 2003). 
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1.3.1.2 Cytokines 
Cytokines are small signalling proteins secreted by immune cells. There are two main types 
of cytokines, according to their different functions. Pro-inflammatory cytokines trigger and 
up-regulate the inflammatory process, such as Interleukin (IL)-1β, IL-6, IL-8, IL-12, IL17, 
IL18 and tumour necrosis factor (TNF). Whilst their role in activating the inflammatory 
cascade is vital, when they are administered systemically to humans, they produce fever, 
inflammation, tissue destruction, and even death (Dinarello, 2000). In contrast, anti-
inflammatory cytokines reduce or halt inflammation and promote healing, and include IL-1 
receptor antagonist, IL-4, IL-10, IL-11 and IL-13 (Opal and DePalo, 2000). 
 
Thus ILs and TNF are very important cytokines. The function of the immune system greatly 
depends on ILs, which were first shown to be secreted by leukocytes, but have since been 
found to be produced by a wide variety of cell types. TNF is a systemic inflammatory 
cytokine, and its main function is the regulation of immune cells. Impairment of TNF 
production has been related to many diseases, including major depression (Dowlati et al., 
2010), Alzheimer’s disease (Swardfager et al., 2010) and cancer (Locksley et al., 2001).  
 
Cytokines are also associated with oxidative stress, which can cause cytokine induction 
(Vlahopoulos et al., 1999; Florent et al., 2007). Cytokines themselves can act in an autocrine 
or paracrine manner, triggering the release of other cytokines (Carpenter et al., 2002; Tian et 
al., 2005), and can also lead to increased oxidative stress, and thus they have an important 
role in chronic inflammation. 
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1.3.1.3 Antigen processing 
Antigen processing is the mechanism by which immune cells prepare antigens for 
presentation to T lymphocytes as part of the adaptive immune process. There are two 
pathways for antigen processing: the endogenous (major histocompatibility complex, class I 
(MHC I)) and exogenous (MHC II) pathways. The endogenous pathway presents intracellular 
peptides to MHC class I molecules that are on the cell surface. The exogenous pathway 
utilizes antigen presenting cells (APCs) to present peptides derived from proteins that the 
APC has endocytosed via MHC class II molecules, also located on the cell surface (Male et 
al.,  2013). 
 
There are two kinds of APCs: professional and non-professional APCs. Professional APCs 
are specialised cells whose primary role is to internalize antigen, and then display part of that 
antigen bound to a class II MHC molecule on their cell membrane. T cells then recognize and 
interact with the antigen-MHC molecule complex. An additional co-stimulatory signal is then 
produced by the APC, leading to activation of the T cell (Dang et al., 1993). There are three 
main types of professional APCs: dendritic cells (DCs), macrophages and B-cells. In contrast, 
the non-professional APCs do not normally express MHC II proteins and include: skin 
fibroblasts, thymic epithelial cells, brain glial cells, pancreatic beta cells and vascular 
endothelial cells (Nickoloff and Turka, 1994). 
 
1.3.2 Skin immune system 
Skin acts as a physical and biological protective barrier for the human body. It protects us 
from potentially harmful agents like microbes, UV light, and so on. As a physical barrier, the 
skin also naturally protects from nanoscale objects such as viruses. What’s more, the skin is 
also an important contributor to human immune system responses. In 1986, Bos JD proposed 
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a distinct “skin immune system” paradigm for the complexity of the immune response-
associated cells present in normal human skin (Bos and Kapsenberg, 1986). Approximately 
half the cell types present in normal human skin have an immune-related function or are local 
immune cells – these cells include: keratinocytes, immature and mature tissue (myeloid) 
dendritic cells, monocytes, macrophages, granulocytes, mast cells, T lymphocytes and their 
subpopulations, and vascular and lymphatic endothelial cells (Bos and Luiten, 2009). 
 
1.3.2.1 Innate and adaptive cells of the skin immune system 
Skin immune system cells may also be divided into two groups, i.e. innate and adaptive cells, 
with both groups taking part in immunosurveillance to protect the body from harmful 
pathogens (Kupper and Fuhlbrigge, 2004). Innate skin immunity is modulated by many 
biochemical and physical factors, some of which are secreted by the sebaceous and sweat 
glands, that recruit cellular components to eliminate pathogens and potentially harmful 
particulates (including NPs). Keratinocytes and macrophages are examples of skin cells 
involved in innate immunity. The adaptive skin immunity includes cells that are essential in 
the second line of host defence against specific pathogens, such as mast cells (Bos, 2005). 
Lymphocytes in the skin are a major part of the adaptive immune response. These 
lymphocytes in the skin can be stimulated by dermal dendritic cells or epidermal Langerhans 
cells, to initiate immune responses. 
 
Dermal dendritic cells and Langerhans cells form a bridge between the innate and adaptive 
immune systems (Banchereau and Steinman, 1998). They can recognize the molecular motifs 
of microbial agents and thereby become activated, leading to the production of pro-
inflammatory cytokines such as TNF-α. During this process, the activation of immature 
dermal dendritic cells and/or epidermal Langerhans cells can be further enhanced by other 
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innate immunity factors, such as the pro-inflammatory cytokines TNF-α and IL-1 that are 
produced by keratinocytes upon contact with pathogens and/or harmful particles (Barker et 
al., 1991). 
 
1.3.2.2 Differences between skin and systemic immunity 
It could be argued that the presence of skin immune cells is the result of a random 
distribution of tissue-infiltrating T lymphocytes, rather than their specific targeting to the skin. 
While it has been proposed by some that there is no difference between skin and systemic 
immunity, there are important differences between these different sites of immunity (Euvrard 
et al., 2003). 
 
One of the primary differences is that the skin is periodically exposed to light and UV 
radiation, which makes the skin cells more tolerant to these factors than systemic immune 
cells. For example, keratinocytes are relative insensitive to the DNA-damaging effects of UV 
exposure and have a high capacity to recover from this form of damage compared to immune 
cells (Surjana et al., 2013). 
 
The skin is also continuously exposed to a variety of antigens from the environment. 
Although the pulmonary and gastrointestinal tracts also have this characteristic, the skin 
immune system responds in a distinctive way to these antigens. In pulmonary and 
gastrointestinal immunology, a major characteristic is the direct submucosal localisation and 
accumulation of lymphoid tissue, which are thought to play a major role in the production of 
secretory IgA, independent of systemic immunity. Although secretory IgA has been detected 
in human cutaneous secretions, the quantity is far lower, and subepidermal extranodular 
lymphoid tissues are not part of normal human skin. Thus, the skin immune system has 
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highly distinct characteristics compared to the pulmonary and gastrointestinal immune 
systems (Bos and Luiten, 2009). 
 
1.3.2.3 Dendritic cells (DCs) 
DCs are one of the most important skin immune cell types and are present in skin, lungs and 
stomach. Their morphology is characterised by the growth of branched projections at certain 
developmental stages. They have the unique capacity to induce primary immune responses, 
and they are divided into those homing to the connective tissues (tissue DCs), the lymphoid 
organs (lymphoid DCs), and epithelia (epithelial DCs: Langerhans cells) (Steinman, 1991). 
 
DCs are among the most important type of APCs involved in immunomodulation, as they 
respond differently to different kinds of pathogens (Akira et al., 2006). If DCs are activated 
by pathogens, they become more effective in priming the adaptive immune system, whereas 
in the absence of activation, immature DCs generally induce T-cell tolerance. Therefore, 
manipulation of DC activation may offer therapeutic potential, such as being an effective way 
to decrease rejection in transplantation (Xiao et al., 2006). 
 
Langerhans cells are members of the DC family, residing in the skin epidermis, respiratory 
mucosa and epithelia of digestive and urogenital tracts. Like the DCs, Langerhans cells also 
have the function of antigen presentation and internalizing antigen, and then migrating them 
to regional lymph nodes, for presentation to naive T cells to initiate the adaptive immune 
response. It is important to note that Langerhans cells are the main immune cells in the skin 
epidermis, and constitute the first immunological barrier (Merad et al., 2008). Therefore, 
investigation of the effect of sunscreen NPs on Langerhans cells is of great significance for 
the use of topical formulations, such as sunscreens and personal care products. 
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1.3.3 Effects of Ultraviolet (UV) light on the human immune system 
UV light from the sun delivers photons that are energetic enough to open bonds in 
heterocyclic organic molecules via oxidative chemistry (Waiblinger et al., 2000). To an 
exposed material, this energy can cause serious degradation over time. For example, sunlight 
causes red rubber items to become brittle in the sun. The same energetic degradation also 
occurs in biological systems.  
 
UV light is usually defined as radiation with a wavelength between 200 to 400 nm, which 
includes three parts of the UV spectrum: UVA (320-400 nm), UVB (290-320 nm) and UVC 
(200-290 nm). Except for industrial activities like arc-welding, UVC is usually not 
biologically-relevant as it is blocked almost entirely by the atmospheric ozone layer. 
However, both UVA and UVB can reach the surface of the earth and cause biological effects 
(van der Mei et al., 2007; Andrady et al. 2012). Overall, UVB causes more biological 
damage than UVA, as UVB contributes to approximately 80% of sunlight’s harmful effects, 
while UVA contributes the remaining 20% (Clydesdale et al., 2001).  
 
1.3.3.1 UV-induced immunosuppression 
There is growing evidence that UV exposure suppresses immune responses to pathogens in 
both experimental animals and humans (Jeevan and Kripke, 1989; Damian et al., 1997; 
Goettsch et al., 1998). As suppression of the immune system is associated with many 
diseases, the immunosuppressive properties of UV radiation are of significant concern. 
 
As well as localised inhibition of skin immune reactions, UV radiation can also affect the 
immune system systemically. Local UV-induced immune suppression, where skin is directly 
UV-irradiated, alters epidermal Langerhans cell function and destroys the DC network. Mice 
 25 
 
sensitized via UV skin irradiation fail to generate a contact hypersensitivity response to 
contact allergens (Toews et al., 1980). In studies of UV-induced systemic immune 
suppression, UV radiation is applied to one site, while an antigen is applied to a distant non-
irradiated site. Immune suppression, both locally and systemically, can be induced with 
relatively low doses of UV. It has been shown that significant immune suppression to 
Mycobacterium bovis Bacille Calmette-Guérin occurs after only 0.35 kJ/m
2
 of UVB exposure, 
which is equivalent to 17.5% of a minimal erythemal dose (MED) of UVB that causes skin 
reddening (Jeevan and Kripke, 1990). It has been shown that UVA doses equivalent to only 6 
minutes of summer sun exposure (as defined in the European Cosmetic Toiletries and 
Perfumery Association Sun Protection Factor (SPF) Test Method (1994)) can suppress 
reactivation of memory immunity in humans (Damian et al., 1999). Halliday and coworkers 
have investigated the wavelength dependency for UV-induced immunosuppression using the 
nickel model of recall immunity in healthy human volunteers. Their study found that UVA 
contributes to approximately 75% of sunlight-induced immunosuppression (Figure 1.4) 
(Matthews et al. 2010a; Matthews et al. 2010b; Halliday et al., 2011).  
 
 
Figure 1.4: Spectrum for UV-induced immunosuppression in humans. [Adapted from 
(Halliday et al., 2011)] 
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1.3.3.2 Mechanisms of UV-induced immunosuppression 
Unlike immunosuppressive drugs that suppress the immune system often non-specifically, 
UV radiation acts in an antigen-specific way. UV exposure induces the generation of T cells 
that specifically suppress immune reactions. These cells, initially called T suppressor cells, 
were recently renamed regulatory T cells (Treg) (Schwarz, 2008). 
 
UV-induced immunosuppression can be examined by suppression of the induction of contact 
hypersensitivity (CHS) by UV radiation. CHS is considered a measure of T cell function, and 
most studies indicate that UV radiation leads to its suppression (Tie et al., 1995). CHS can be 
divided into two phases, the first is sensitisation phase and the second is elicitation phase. In 
sensitisation phase, small haptens react with proteins locally in the skin to create hapten-
derivatised proteins, which are taken up by Langerhans cells and presented to specific T cells. 
In the elicitation phase, T cells are activated, releasing particular cytokines that lead to 
infiltration of macrophages and neutrophils, and a colour change (e.g. erythema) or swelling 
(e.g. oedema) (Halliday et al., 2012). 
 
When skin is exposed to UV radiation, a multistep process is triggered. The photo receptors 
in the skin (also called the initiators) convert the physical energy contained within the UV 
radiation into a biologically recognisable signal. Epidermal DNA and trans-urocanic acid 
(UCA) have both been shown to absorb UV energy to initiate immune suppression (Ullrich, 
2005). 
 
Specifically, UV-induced DNA damage has been recognized as the major trigger for most of 
the biological effects of UV radiation (Kripke et al., 1992). UV absorption by cellular DNA 
results in various types of damage, such as the formation of cyclobutane pyrimidine dimers 
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(CPDs) and 6,4-photoproducts. DNA repair enzymes bind to the CPDs and revert them to the 
original pyrimidines (Ley et al., 1991). 
 
There are two forms of UCA, i.e. trans- and cis-UCA; with UV exposure converting trans-
UCA into the immunosuppressing cis-UCA (Norval et al., 1995). It has been found that 
direct injection of cis-UCA partially mimics the immunoinhibitory activity of UV radiation 
(Kondo et al., 1995). In addition, cis-UCA also inhibits the presentation of tumour antigens 
by Langerhans cells (Beissert et al., 1997). 
 
1.4 Effects of NPs on the human immune system 
The NPs that are capable of entering the body are certain to encounter immune cells. 
Different types of NPs may have different effects on the immune system, as some NPs may 
stimulate the immune system, while others may suppress it. Thus rigorous investigation of 
the effects of different types of NPs on the functions of a range of immune cells is a very 
important aspect of nanosafety research. 
 
1.4.1 Immunostimulatory properties of NPs 
The immune system efficiently recognizes foreign substances and mounts a multilevel 
immune response against them. NPs can also stimulate immunity or trigger an immune 
response, which has many potential outcomes, some as severe as the induction of allergy or 
autoimmune diseases (Zolnik et al., 2010). As stated previously, the potential for an 
inflammatory response is very important to the assessment of NP bioactivity.   
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1.4.1.1 Inflammatory responses to NPs 
During inflammation, immune and non-immune cells may interact with the penetrating NPs 
to trigger an inflammatory response mediated by cytokines, which will attract more immune 
cells and begin a process to clear the NPs. 
 
The surface chemistry of NPs is a key factor in their reactivity with the immune system. In 
general, cationic (positively-charged) NPs are more likely to induce inflammatory reactions 
than anionic (negatively-charged) and neutral NPs (Kedmi et al., 2010). For example, the 
binding ability of NPs to macrophages is determined by the NP charge displayed to the cell. 
As macrophages display negatively-charged sialic acid groups on their surface, cationic NPs 
are more likely to bind and affect macrophages than anionic or neutral particles, potentially 
inducing inflammation (Dwivedi et al., 2009).  
 
NP uptake by immune cells may occur in monocytes, platelets, granulocyte, dendritic cells 
and, most significantly, in macrophages, which may lead to inflammation (Dobrovolskaia and 
McNeil, 2007). Different NPs can modulate the inflammatory responses of macrophages in 
different ways. Lucarelli and coworkers (Lucarelli et al., 2004) investigated the effects of 
SiO2, TiO2, ZrO2 and cobalt NPs on human macrophages in vitro by examining their 
inflammatory responses (via expression of Toll-like receptor (TLR), co-receptors and 
cytokine production). They found that SiO2 NPs induced the production of inflammatory 
cytokines, while Co NPs induced pro-inflammatory effects overall. In contrast, TiO2 and 
ZrO2 NPs did not alter the expression of viral TLR receptors in the study. 
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1.4.1.2 Effect of NPs on cytokines 
As previously mentioned, cytokines are inflammatory signalling proteins secreted by both 
immune and non-immune cells, and are used extensively in intercellular communication. 
Cytokine immune signalling in human immune cells has been employed as a biomarker to 
investigate the immune response (Elsabahy et al., 2010). 
 
Several studies have investigated the effect of NPs on cytokine responses. One in vitro study 
of the potential interference of Co NPs on the production of several cytokines in peripheral 
blood mononuclear cells (Petrarca et al., 2006), found that Co NPs induced TNF-α and IFN-γ 
release and inhibited IL-10 and IL-2 production in a cytokine pattern similar to that detected 
in experimental and clinical autoimmunity. Feltis and coworkers (Feltis et al., 2012) 
investigated the cytokine release of THP-1 monocytes exposed to ZnO NPs. In their study, 
they examined 11 different cytokines of NP-exposed cells by multiplex flow cytometry and 
ELISA. They found that the cytokine profile of ZnO NP-exposed cells is independent of their 
cytotoxic response to ZnO NPs. In addition, they also found very strong IL-8 responses, 
which were dependent on NP size, i.e. as particle size decreased, IL-8 expression increased.  
 
1.4.2 Immunosuppressive properties of NPs 
Immunosuppression is the potential for an agent to suppress immunity or an immune 
response. Pharmaceutical down-regulation of the immune response may be beneficial in the 
treatment of some inflammatory disorders, whereas undesirable immunosuppression could 
lead to increased susceptibility to infections and cancer (Dobrovolskaia and McNeil, 2007). 
Some NPs have also exhibited immunosuppressive properties. 
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It has been found that polymerized lipid NPs prevent eosinophils (a type of granular 
leukocyte) from binding to targeted selectins, which in turn decreases local inflammation and 
prevents tissue damage (John et al., 2003). Cerium dioxide (CeO2) NPs have been found to 
be effective in reducing ROS (Xia et al., 2008) and inflammatory mediator production, and 
have potential use as a novel therapeutic tool for the treatment of inflammation.  
 
In addition, nanodiamonds (NDs) have been reported to help the healing process and 
therefore could be employed as a treatment in oncology, cardiology, dermatology, and 
vascular diseases treatment (Schrand et al., 2007). However, NDs were also found to increase 
ROS generation in leukocytes in vitro (Puzyr et al., 2002). The effects induced by ND 
particles appear to depend on both its concentration and surface properties (Dwivedi et al., 
2009). 
 
Many NPs can therefore be engineered to have immunosuppressive properties and may 
potentially be developed into new therapeutic tools for the treatment of chronic inflammation. 
However, undesirable immunosuppression from non-therapeutic exposure may occur, and 
thus immunotoxicity tests are an important part of preclinical NP evaluation (Dobrovolskaia 
and McNeil, 2007).  
 
1.4.3 Reactive oxygen species (ROS) generation and oxidative stress 
ROS are chemically reactive molecules containing oxygen; they include hydrogen peroxide 
(H2O2), superoxide (O2
.-
) and the hydroxyl radical (
.
OH). The accumulation of ROS increases 
the oxidative stress to the cell, which leads to adverse biological consequences. Oxidative 
stress is an imbalance between ROS production and the cell’s antioxidant defences (Xia et al., 
2006). For example, reduced glutathione (GSH) is an antioxidant that protects against ROS 
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induced cell damage, and when oxidative stress occurs, GSH is converted to oxidised 
glutathione (GSSG) (Pompella et al., 2003). As a result, the GSH/GSSG ratio serves as a 
measure of the state of oxidative stress (Halliwell and Gutteridge, 2007). Under normal 
conditions, the level of oxidative stress is very low and thus the GSH/GSSG ratio is high. 
Conversely, when the GSH/GSSG ratio is low, there is a high level of oxidative stress in the 
cell. 
 
ROS serves an important role in both photocarcinogenesis and skin aging (Toyokuni, 1998). 
In addition, ROS can induce DNA damage, such as a single- and/or double-strand DNA 
breaks, base modifications (e.g. formation of 8-hydroxydeoxyguanosine) and DNA cross-
links, all of which, if unrepaired, can lead to carcinogenesis (Martinez et al., 2003). 
 
1.4.3.1 Effects of ROS generation from NP exposure 
Increased ROS generation by NPs is responsible for oxidative stress in the cell. There is a 
direct relationship between the ROS generating capability and the pro-inflammatory effects 
of some NPs (Nel et al., 2006). Andre Nel’s research group has shown that the hazards of 
many NPs are best predicted by examining the ROS generation and oxidative injury caused 
by those NPs (Xia et al., 2006).  
 
However, not all NPs will produce ROS. For example, TiO2 only produces ROS in sunlight 
(specifically in the anatase form), while other types may produce a lot or none at all, 
depending on the material. It is important to note that NPs are most often catalysts in the 
production of ROS, and once in situ, may continue to produce ROS indefinitely (Tran and 
Salmon, 2011). Furthermore, the high surface area properties of NPs can promote the 
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generation of ROS. Taken together, ROS generation by NPs is clearly an important aspect of 
their potential toxicity. 
 
There are various methods available which could potentially reduce the production of ROS 
caused by NPs. These include adding manganese to the TiO2 NP crystal matrix (Wakefield et 
al., 2004), coating NPs with aluminium-oxide or silicon oxide (Allen et al., 2005) or 
liposomal encapsulation (Bennat and Muller-Goymann, 2000; Lee et al., 2007). Other 
methods include the addition of antioxidant compounds that are sometimes used in sunscreen 
formulations, including vitamins A, E and C, and b-carotene (Pinnell, 2003). 
 
1.4.3.2 Hierarchical oxidative stress model 
A hierarchical oxidative stress model has been developed in Andre Nel’s research group to 
study the oxidative injury made by NPs (Li et al. 2002; Xiao et al., 2003; Xia et al., 2006). At 
the lowest level of oxidative stress (Tier 1), there are more than 200 protective phase II 
antioxidants that are regulated by nuclear factor erythroid-2-related factor 2 (Nrf2) (Cho et al. 
2006; Li and Nel, 2006). These phase II antioxidants include glutathione S-transferase (GST) 
isoenzymes, superoxide dismutase (SOD), NADPH quinone oxidoreductase 1 (NQO1), heme 
oxygenase 1 (HO-1), catalase, and glutathione peroxidase (Chan and Kan, 1999; Cho et al., 
2002; Li and Nel, 2006). Due to the presence of this large and varied pool of cellular 
antioxidants, there is some considerable benefit from the protective response to Tier 1, and 
therefore particle-induced ROS generation does not automatically lead to adverse biological 
events.  
 
If the initial protective responses (Tier 1) are inadequate, a further increase in ROS 
production can result in pro-inflammatory (Tier 2) and cytotoxic (Tier 3) effects. Pro-
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inflammatory effects, caused by an intermediate level of oxidative stress, are mediated by the 
redox-sensitive MAP kinase and NF-κB cascades that are responsible for the expression of 
cytokines, chemokines, and adhesion molecules (Chan and Kan, 1999; Li et al. 2003; Xiao et 
al., 2003).  
 
If the pro-inflammatory (Tier 2) effects cannot be protected against, then the highest level of 
oxidative stress (Tier 3), i.e. cytotoxic effects, will occur. At this level, perturbation of 
mitochondrial permeability transition pores and disruption of electron transfer results in 
cellular apoptosis or necrosis (Hiura et al., 2000; Xia et al., 2004). This Tier 3 level is also 
known as toxic oxidative stress.  
 
1.4.3.3 Oxidative stress from NPs 
Andre Nel’s group also adapted their hierarchical oxidative stress model for NP exposure to 
investigate the oxidative stress caused by NPs (Xia et al. 2006; Xia et al. 2008). They 
assessed different markers for the three tiers of oxidative stress as described above, including 
Nrf2, HO-1 and NQO1 for Tier 1 oxidative stress responses and found that ZnO NP exposure 
lead to HO-1 mRNA and protein expression and increased Nrf2 and NQO-1 mRNA 
expression in RAW264.7 phagocytic cells and BEAS-2B bronchial epithelial cells. 
Conversely, CeO2 and TiO2 NPs did not induce these Tier 1 biomarkers (Xia et al., 2008).  
 
For the Tier 2 response, these researchers employed Jun Kinase (JNK), a member of MAP 
kinase family, as a biomarker and found that ZnO NPs could effectively induce JNK 
activation in RAW 264.7 and BEAS-2B cells (Xia et al. 2006; Xia et al. 2008). Finally, for 
the Tier 3 response, they employed intracellular free calcium measurements and changes in 
mitochondrial membrane potential as biomarkers and found that ZnO NPs induced a 
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significant and persistent Ca
2+
 increase, and could lower mitochondrial membrane potential 
in both cell lines (Xia et al., 2008). 
 
As oxidative stress plays such an important role in the metabolism of the cell, such systematic 
studies of the effect of NPs on cell oxidative stress is of great significance. However, there 
are factors that still need to be explored. Firstly, NPs were studied in normal cell culture 
medium containing fetal bovine serum (FBS), which contains high levels of antioxidants that 
may mask the oxidative effects of NPs. NPs may therefore be introduced to cells that are not 
affected by FBS-free culture media in order to avoid this effect. Secondly, there is the 
important situation of NPs that are formulated into sunscreens and their intended use results 
in co-exposure to UV. The effect of combined exposure to UV light and NPs on oxidative 
stress in cells is still not well known. Consequently, a significant amount of further work is 
required to thoroughly investigate this specific aspect of NP effects on cellular oxidative 
stress. 
 
1.5 Conclusion 
Because of the unique properties of nanomaterials, nanotechnology is employed in nearly 
every aspect of our life. However, we must still be cautious as very little is known about the 
potential risks of NPs and their novel properties, such as their high surface area leading to 
enhanced reactivity, while their extremely small size may lead to increased bioavailability – 
both increasing the potential for adverse biological effects. Unfortunately, the study of 
nanosafety has lagged far behind the development of new applications of nanomaterials, and 
we should no longer delay the comprehensive and systematic study of the potential risk posed 
by widely-used NPs. Tissue resident immune cells are the first point of contact where NPs 
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can be actively sequestered by cells, and investigations into their effects on the function of 
immune cells is a very urgent and important aspect of nanosafety research.  
 
It is suggested by many literature reports that ROS generation is related to effects of some 
NPs, however the relationship between ROS and NPs still needs further investigation. 
Modulation of the ROS production and cytotoxicity of NPs may help answer the question. 
Although there are some studies of the effect of NPs on the human immune system, few have 
examined the potential for altered antigen presentation of immune cells by NP exposure, 
which warrants further investigation.  
 
1.6 Scope and project outline 
Despite the advent of new transparent sunscreens containing NPs of UV-filtering zinc and 
titanium oxides, the effect of these compounds on innate immunity is poorly understood. This 
is particularly important as tissue resident immune cells are a first point of contact where NPs 
can be actively sequestered by cells. In preparing sunscreen formulations, NPs are also being 
coated with various surfactants – affecting their solubility, bioavailability and dermal 
penetration, which may also alter their potential inflammatory properties. As there is growing 
use of such substances in sunscreens, which are crucial to public health in Australia, their 
safety needs to be established.  The aim of this project is to investigate the effect of metal-
oxide NPs used in sunscreens on the function of immune cells of the skin. Specific emphasis 
was placed on the role of zinc ion release, ROS generation, and altered immune functions by 
exposure of ZnO NPs, and direct comparisons made with TiO2 NPs. 
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In this project, the effect of ZnO and TiO2 NPs on the function of skin immune cells was 
examined. Firstly, physicochemical properties of NPs are very important to their biological 
effects and potential toxicity. For this project, different particle sizes, surface coating and 
shapes of ZnO and TiO2 NPs were exposed to several human immune cell types that are 
present in skin, such as monocytes, macrophages and dendritic cells (representing skin 
Langerhans cells), and their cytotoxicity profiles were assessed. Secondly, the hazards of NPs 
are best predicted by examining a range of bioactivities, including the ROS generation, 
oxidative injury and cytokine production caused by NP exposure. These parameters were 
therefore investigated in the various human immune cell types following NP exposure. In 
addition, as these metal oxide NPs are commonly formulated in sunscreens, the extent and 
effects of ROS generation with UVA and NP co-exposure were measured, which is highly 
relevant to sunscreen usage.  
 
This project will provide important information on the cellular responses of innate immune 
cells exposed to sunscreen metal-oxide NPs that will help in the safety evaluation of these 
products, as well as in the safety-by-design approach to developing more effective, less 
allergenic sunscreen formulations. 
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Chapter 2. General materials and methods 
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2.1 Particle characterisation 
Particulates require careful and appropriate handling and characterization in order to obtain 
reproducible experimental results. 
 
ZnO NPs of 30, 80, and 200 nm, with and without a surfactant dispersant (approximately 5% 
by weight of Orotan 731 DP, a sodium polyacrylate) were supplied by Micronisers Pty. Ltd. 
(Melbourne, Australia). TiO2 anatase (25 nm) and rutile (34 nm) NPs were purchased from 
commercial suppliers. The synthesis of cobalt-doped ZnO (3.5 at% Co) has been previously 
reported by our research group (Casey et al., 2006). 
 
Particulate suspensions were prepared in milliQ water for primary particle size analysis by 
transmission electron microscopy (TEM) and dynamic light scattering (DLS). TEM samples 
for particle size analysis were prepared by pipetting a 4 μL aliquot of the relevant NP 
suspension in water on a nitrogen glow-discharged, 300-mesh, copper TEM grid, covered 
with amorphous carbon film. Excess liquid was wicked from the grid and then allowed to air 
dry. Grids were imaged at a number of different locations to obtain a representative sample of 
each type of particulate. DLS measurements of primary particle size distribution were 
performed on a Zetasizer Nano ZS (Malvern) at the Nanometrology section of the National 
Measurement Institute, Lindfield, New South Wales, Australia. Each sample was prepared by 
weighing the appropriate amount of NPs and diluting with milliQ water for a final 
concentration by weight of 200 μg/mL, 24 hr before measurement. Aliquots of 1 mL per 
sample were loaded into polystyrene cuvettes for analysis. The instrument used a 633 nm He-
Ne laser with a scattering angle of 173°. Each measurement was performed in triplicate at a 
temperature of 20°C. 
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Size distribution and agglomeration of particle suspensions in RPMI-1640 (Sigma, USA) 
media and RPMI-1640 media plus fetal bovine serum (FBS, Sigma) were determined 
quantitatively using a DC1800 disc centrifuge (CPS instruments, USA), with an RPMI-1640 
media and sucrose gradient, and confirmed qualitatively by cryo-transmission electron 
microscopy (cryo-TEM) using a FEI Tecnai G2 (FEI Company, USA).  
 
Disc centrifugation sedimentation (DCS) was undertaken on NPs that had been incubated in 
cell culture media containing 10% FBS for at least 24 hr prior to analysis. 15 mL of a 
gradient solution containing 24% w/w sucrose dissolved in RPMI-1640 culture media was 
loaded into the disc and spun at 24000 RPM for 60 min to equilibrate. An aliquot of 100 μL, 
at desired concentration of NPs, was directly injected onto the disc for each sample. A 
standard consisting of polystyrene beads with a diameter of 390 nm was used to calibrate the 
system before each measurement. Particles are assumed to be spherical and have uniform 
density for diameter calculations. 
 
Cryo-TEM samples were prepared to examine particle agglomeration in cell culture media by 
pipetting a 4 μL aliquot of the relevant NP suspension in media onto a nitrogen glow-
discharged 300-mesh copper TEM grid covered with lacy formvar-carbon film (ProSciTech, 
Queensland, Australia). After 30 sec the grids were blotted with filter paper then plunged into 
liquid ethane cooled with liquid nitrogen. This caused the cell culture media containing NP to 
form vitreous ice which is effectively transparent to electrons, providing a good model of the 
agglomeration state of the NP in the in vitro culture conditions. The frozen grids were stored 
in liquid nitrogen until required. They were examined using a Gatan 626 cryoholder (Gatan, 
California, USA) to keep them below -170°C to prevent the samples from de-vitrifying. 
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2.2 Particle preparation for in vitro studies  
Particulates were handled and prepared following a defined protocol to obtain reproducible 
suspensions for each experiment. All NPs for in vitro studies were dispersed into stock 
solutions prior to being diluted into working solutions. To make the stock solution, 20-40 mg 
of particulate was weighed out and placed into a 5 mL flat bottom tube, and milliQ water 
added to achieve a concentration of 20 mg/mL. Then the stock solution was ultra-sonicated 
(150 W) for 15 mins to disperse and sterilize the solution. After the ultra-sonication, the stock 
solution was diluted to working solution as follows: the stock solution was vortexed for 30 
sec and inverted 10-20 times, and then resuspended by pipetting up and down 3-5 times, 
before the desired volume of stock solution was added to the media to make 1 mg/mL 
working solution. Dilutions were made by inverting the working solution 3-5 times, or until 
no particles were stuck to the bottom of the tube, and pipetting up and down 5 times, before 
the desired volume of the working solution was added to the media. Considering the NP 
dissolution and corona formation, NP dilutions were left to stand for 24 hr before dosing into 
the microplates, as the interaction of NPs and protein in the media are also important to the 
uptake of the particle. It is known that protein in the media can form a corona, and this 
corona-NP complex can engage in the uptake process (Dawson et al., 2009). 
 
2.3 Cell culture 
This project involved the culturing, and incubation with NPs, of five cell types: the human 
acute monocytic leukemia cell line THP-1, and THP-1 differentiated macrophages; primary 
human lymphocytes isolated from peripheral blood; human acute myelomonocytic leukemia 
cell line MUTZ-3, and MUTZ-3 differentiated LCs. All cell cultures and cell culture 
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exposures were kept in a humidified incubator at 37°C with a 5% CO2 atmosphere. All cell 
culture media and solutions for exposures and culturing were kept at 37°C using a water bath, 
unless otherwise stated. Cell culture and exposure experiments were performed under aseptic 
conditions in a class 2 biohazard containment hood, and the containers of materials were 
sterilised by spraying with 70% v/v ethanol in water prior to drying under the sterile airflow 
within the biohazard hood. Cells were cultured in Cellstar
®
 75 cm
2
 filter-cap polystyrene 
culture flasks (Greiner Bio-One, Cat. No. 658 175; Greiner, USA) and exposures were 
carried out in Cellstar
®
 96-well polystyrene, flat bottomed microplates (Greiner Bio-One, Cat. 
No. 655 180; Greiner). 
 
2.3.1 THP-1 cell line  
The human acute monocytic leukemia cell line (THP-1) (kindly provided by Department of 
Medicine, University of Melbourne, Melbourne, Australia) was cultured THP-1 culture 
media (TCM) which consisted of RPMI-1640 media containing 10% FBS (Australian origin, 
SAFC Biosciences, Sigma-Aldrich Corporation), 100 mg/L gentamycin, 4.5 g/L D-glucose 
(AnalaR, BDH), 1 mM pyruvate (ReagentPlus
®
, Sigma-Aldrich), 0.05 mM 2-
mercaptoethanol (BioReagent, Sigma-Aldrich) and 2 mM L-glutamine (BioReagent, Sigma-
Aldrich) supplementation. Cells were cultured in a humidified incubator at 37°C and 5% CO2. 
The cells were cultured to a cell density of between 1 and 2×10
6
 cells/mL before being 
subcultured into fresh media at a dilution factor of 1 in 10, usually once a week, with a 
doubling time of approximately 26 hr. 
 
In the in vitro NP exposure system, cells were centrifuged and resuspended in fresh TCM 
before seeding into 96-well plates in a volume of 100 µL at 10
5
 cells per well. NPs suspended 
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in TCM were added for a final concentration of 1–100 µg/mL, in a final incubation volume of 
200 µL per well.  
 
Macrophages were differentiated from THP-1 monocytes by incubating 8×10
4
 cells per well 
with 20 nM of phorbol-12-myristate-13-acetate (PMA) for 24 hr. Cell photographs were 
taken via phase contrast light microscopy (Figure 2.1). Macrophage differentiation was 
confirmed by examining cellular morphology using light microscopy. After which the media 
was aspirated off and fresh media containing NPs at a concentration of 1–100 µg/mL was 
added. 
 
 
Figure 2.1. Optical microscopic images of THP-1 monocytes (A) and macrophages (B), at 
40x objective magnification for both images. 
 
Although PMA has the capability of stopping cell growth, some THP-1 cells still proliferated 
during the 24 hr period. The lower initial cell concentration was employed to allow for some 
cell growth during the 24 hr differentiation period – this was needed to obtain the same 
approximate macrophage cell number per well as was present in the monocyte-containing 
wells, prior to the addition of particulates and commencement of in vitro exposures. This 
appropriate cell density for seeding wells prior to differentiation by PMA was experimentally 
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determined as follows. Two different initial THP-1 cell densities (5×10
4
 and 8×10
4
 cells per 
well in a volume of 100 µL) were seeded into wells for PMA-induced macrophage 
differentiation, alongside wells containing unstimulated monocytes, and the cell numbers in 
each well were determined after 24 hr of incubation by the trypan blue exclusion assay. From 
Figure 2.2, we can see that macrophages differentiated from THP-1 monocytes at a seeding 
cell density of 8×10
4
 cells per well arrived at the same approximate cell number after 24 hr as 
the initial cell density of monocytes used for in vitro exposures (i.e. 10
5
 cells per well). 
 
 
Figure 2.2. Confirmation of cell numbers in THP-1 cell line differentiation protocols. Two 
seeding cell density (5×10
4
 and 8×10
4
 cells per well) were used for macrophage 
differentiation; after 24 hr incubation the cell numbers were determined by trypan blue 
exclusion assay (mean ± SE of triplicate samples). 
 
The extent of monocyte differentiation into macrophages using this protocol was specifically 
determined by cell surface marker expression using flow cytometry (FACS Canto II, Becton, 
Dickinson and Co., Franklin Lakes, NJ, USA), and employing Pacific Blue anti-human 
CD11b Antibody (BD Bioscience, Cat. No. 558123, USA) as per the manufacturer’s 
instructions. The THP-1 monocytes that were not incubated with PMA exhibited a tailing in 
its blue fluorescence histogram, and a nominal gating (region “P2”) indicated that this 
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monocyte population was 4% positive for the macrophage specific cell surface marker 
(Figure 2.3B). After 24 hr incubation with PMA, the same gating region showed that 
approximately 50% of the cells were positive for the macrophage differentiation marker 
(Figure 2.3D). The red dots in the 2-D flow cytometry plots of forward vs. side-scatter 
(Figures 2.3A & 2.3C) represent the undifferentiated monocytes, while the blue dots 
represent monocytes that have differentiated into macrophages and express the macrophage 
marker. From the 2-D plots we can also see that after the 24 hr differentiation protocol, the 
cell has become more granular (i.e. increased side-scatter) and slightly larger (i.e. increased 
forward scatter), which was also confirmed by the optical microscopy images (Figure 2.1).  
 
Figure 2.3. Confirmation of the extent of PMA-induced differentiation of THP-1 monocytes 
to macrophages. A & C are Forward vs Side-scatter plots; B & D are histograms of blue 
fluorescence intensity (gated on region “P1” in A & C). A & B are THP-1 monocytes without 
PMA; C & D are THP-1 cells after incubation with 20 mM PMA for 24 hr (Typical plots 
shown for one of 3 incubations analysed for each condition.). 
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2.3.2 Primary human lymphocytes 
Primary human leukocytes were isolated from ‘buffy-coat’ material sourced from the 
Australian Red Cross Blood Service (Melbourne, Australia), which is a by-product of blood 
donations containing immune cells (under RMIT University Human Research Ethics 
Committee project number 29/08). BD Vacutainer
®
 CPT glass molecular diagnostic tubes 
(BD, New Jersey) containing Ficoll™ medium and 0.1 mL of 0.1 M sodium citrate were used 
to separate leukocytes from any remaining erythrocytes in the buffy-coat. After centrifuging 
the tubes at 1500 g for 15 min at room temperature, the interphase band containing the 
leukocytes was removed along with the serum and collected in a 50 mL centrifuge tube. This 
was centrifuged at 300 g for 5 min and the supernatant was discarded. The cell pellet was 
resuspended in 25 mL of warm phosphate buffered saline (PBS) (made from Sigma-Aldrich 
PBS tablets and milliQ water, sterilised at 121°C) and centrifuged again at 300 g for 5 min to 
remove any residual platelets. This wash step was repeated twice. Following this, the 
leukocytes were resuspended in 25 mL of TCM and counted to determine the concentration. 
The leukocyte suspension was diluted to a concentration of approximately 5 × 10
6
 cells/mL 
in warm TCM and 15 mL of this suspension was added to 75 cm
2
 culture flasks and 
incubated at 37°C for 90 min to allow the monocytes to attach. Following the attachment step, 
the supernatant was transferred to another flask, and returned to the incubator. After 
overnight incubation, the remaining small portion of monocytes was attached to the flask, and 
the lymphocytes were collected in the supernatant.  
 
2.3.3 MUTZ-3 cell line 
The human acute myelomonocytic leukemia cell line MUTZ-3 (Deutsche Sammlung von 
Mikroorganismen und Zellkulturen [DSMZ], Braunschweig, Germany) was cultured in 
MEM-α medium containing ribonucleosides and deoxyribonucleosides (Life Technology, Cat. 
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No. 12571, USA), 1 g/L glucose (Sigma, USA) and 2 mM L-glutamine (Sigma, USA) 
supplemented with 20% FBS, 100 mg/L gentamycin (Sigma, USA), and 10% 5637-
conditioned medium (Hu et al., 1996;  Masterson et al., 2002). Cells were cultured in a 
humidified incubator at 37°C and 5% CO2. Cells were centrifuged and resuspended in fresh 
media before seeding into 96-well plates at 10
5
 cells per well. LCs were differentiated from 
MUTZ-3 monocytes by 9 days of stimulation with 100 ng/ml GM-CSF (Life Technology, 
Cat. PHC6025), 2.5 ng/ml TNF-α (Life Technology, Cat. PHC3015) and 10 ng/ml TGF-β1 
(Life Technology, Cat. PHG9204), and every three days replacement cytokines were added in 
fresh media (Santegoets et al., 2006). Cell photographs were taken by phase contrast light 
microscopy (Figure 2.4). After 9 days of stimulation, both stimulated and unstimulated cells 
were diluted in fresh media before seeding into 96-well plates at 10
5
 cells per well. NPs 
suspended in tissue culture media were added for a final concentration of 10–100 µg/mL, in a 
final incubation volume of 200 µL per well. 
 
 
 
Figure 2.4. Optical microscopic images of MUTZ-3 monocytes (A) and LCs (B), at 40x 
objective magnification for both two images.  
 
 47 
 
In this study, the extent of differentiation was specifically determined by cell surface marker 
expression using flow cytometry and the phycoerythrin (PE) labelled anti-human CD207 
Langerin antibody (BioLegend, Cat. No. 352204, USA) as per the manufacturer’s 
instructions.   
  
The MUTZ-3 monocytes that were not incubated with cytokines exhibited a tailing in its 
orange fluorescence histogram, and a nominal gating (region “P2”) indicated that this 
monocyte population was 4% positive for the LC-specific cell surface marker (Figure 2.5B). 
After 9 days incubation with GM-CSF, TNF-α and TGF-β1, the same gating region showed 
that approximately 50% of the cells were positive for the LC differentiation marker (Figure 
2.5D). The red dots in the 2-D flow cytometry plots of forward vs. side-scatter (Figures 2.5A 
& 2.5C) represent the undifferentiated monocytes, while the blue dots represent monocytes 
that have differentiated into LCs and express the LC marker. From the 2-D plots we can also 
see that after 9 days of differentiation, the cell has become larger and more granular, which 
was also confirmed by the optical microscopy images (Figure 2.4). 
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Figure 2.5. Confirmation of the extent of differentiation of the MUTZ-3 monocytes to LCs. A 
& C are Forward vs Side-scatter plots; B & D are histograms of orange fluorescence intensity 
(gated on region “P1” in A & C). A & B are MUTZ-3 monocytes without cytokine treatment; 
C & D are MUTZ-3 cells after stimulation with GM-CSF, TNF-α and TGF-β1 for 9 days 
(Typical plots shown for one of 3 incubations analysed for each condition.).  
 
2.4 Cytotoxicity assays 
The cytotoxicity profile of particulates was examined in this project using three separate 
measurements of cell viability. 
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2.4.1 Trypan blue exclusion assay 
Trypan blue is a cellular stain that is excluded by the cell membranes of viable cells, and can 
be used to distinguish between viable and non-viable cells by light microscopy (Strober, 
2001). For suspended cells, the samples were simply diluted 1:1 with 0.4% w/v trypan blue 
solution and then pipetted into an improved Neubauer haemocytometer to visually count the 
number of live and dead cells. For attached cells, the sample supernatant was removed and 
collected in a microfuge tube. The sample wells were then washed twice with PBS and these 
washings were transferred to the same microfuge tube. Following washing, the samples were 
incubated with 100 μL of TrypLETM Express (Invitrogen, CA, USA) for 5 min at 37°C, 
before being dislodged by repeated pipetting and then transferred to the same microfuge tube. 
Samples were then centrifuged at 200 g for 5 min and resuspended in 200 μL of PBS. 
Samples were then stained and counted as described above. 
 
2.4.2 MTS viability assay 
The main assay used to determine cell viability in this project employed a system called 
CellTiter 96® Aqueous Non-Radioactive Cell Proliferation Assay (Promega), or the MTS 
assay. The MTS reagent is reduced by viable cells through interaction with dehydrogenase 
enzymes to produce a soluble formazan dye which absorbs light strongly at 490 nm (Promega, 
2009). The amount of light absorbed is directly proportional to the number of viable cells 
present.  
 
In this project, MTS reagent (40 μL) was added to samples in 96-well plates (final volume 
200 μL per well) 4 hr before the desired exposure time-point. After adding MTS reagent, the 
microplates were incubated for 4 hr in the dark under the cell culture conditions described in 
section 2.3. After which, the absorbance at a wavelength of 490 nm was recorded using a 
 50 
 
plate reader (FlexStation 3 Microplate Reader, Waltham, CA, USA). Wells containing the 
concentration range of NPs and MTS reagent alone were used to control for any direct optical 
density effects of NPs, by subtracting these values from the experimental readings. Finally, 
the absorbance of each sample was divided by the absorbance of the control wells (without 
NPs) to provide cell viability values as a percentage of control. Each treatment was 
performed in triplicate per experiment, over three experiments. 
 
2.4.3 Propidium Iodide (PI) fluorescence based assay 
PI is a red fluorescent vital dye (Ex 493 nm/Em 630 nm), which can bind to DNA and RNA 
but is excluded from cells with an intact cell membrane (Darzynkiewicz et al., 1992). 
Therefore, the number of PI positive cells is directly proportional to the number of nonviable 
cells present. Flow cytometry was used to perform the PI fluorescence-based cell viability 
assay as follows. After exposure of the cells to NPs, samples were washed with PBS. 
Samples were then incubated with PI (Beckman Coulter, California, USA) for 15 min in the 
dark. After which samples were washed again to remove the extracellular PI and analysed by 
flow cytometry within 30 min. Each treatment was performed in triplicate per experiment, 
over three experiments. 
 
2.5 Intracellular ROS generation 
The generation of intracellular ROS in the in vitro experiments were measured using 
fluorescent assays that were compatible with flow cytometry, and with specificity for 
detecting either intracellular peroxides or mitochondrial superoxide. 
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2.5.1 Intracellular peroxide generation 
Peroxide generation was measured by 2′,7′-Dichlorofluorescin diacetate (DCFDA) (Sigma, St 
Louis, MO, USA). Cells were centrifuged and then resuspended in fresh media at a 
concentration of 10
6
 cells/mL. Cells were then washed in PBS, which was followed by the 
addition of 100 µM DCFDA. Cells were then incubated for 30 min in a dark and humidified 
incubator at 37°C and 5% CO2 to allow for uptake. Cells were washed again with PBS to 
remove extracellular DCFDA, after which fresh media was added. Cells were then seeded 
into black 96-well plates at 10
5
 cells per well. NPs suspended in tissue culture media were 
added for a final concentration of 10–100 µg/mL. After the desired exposure time-points, 
cells were analyzed using a FlexStation 3 plate reader with excitation and emission 
wavelengths of 485 and 530 nm, respectively. Each treatment was performed in triplicate per 
experiment, over three experiments. 
 
2.5.2 Mitochondrial superoxide generation 
Mitochondrial superoxide generation was measured by MitoSOX
TM
 Red (Invitrogen, CA, 
USA), a derivative of dihydroethidium (Ex 510 nm/Em 580 nm). Cells were centrifuged and 
resuspended in fresh media at a concentration of 10
6
 cells/mL. Cells were then washed in 
Hank’s Balanced Salt Solution (HBSS), which was followed by the addition of 2.5 µM 
MitoSOX
TM
 Red that was then incubated for 30 min in a dark and humidified incubator at 
37°C and 5% CO2 to allow for uptake. Cells were then washed again with HBSS to remove 
extracellular MitoSOX
TM
 Red, after which fresh media was added. Cells were then seeded 
into 96-well plates at 10
5
 cells per well. ZnO NPs suspended in tissue culture media were 
then added for a final concentration of 10–100 µg/mL, at a final volume of 200 µL. After the 
desired exposure time-points, cells were analyzed using flow cytometry. Each treatment was 
performed in triplicate per experiment, over three experiments.  
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Chapter 3. Relating cytotoxicity, zinc ions and 
ROS in ZnO NP-exposed human immune cells 
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3.1 Introduction 
As a result of their high surface-area-to-volume ratio, nanomaterials demonstrate high levels 
of reactivity when compared to their bulk material counterparts (Roduner, 2006).  While this 
characteristic means that NPs are useful in many industrial and medical applications, the 
potential for increased exposure to reactive NPs mean that a deeper understanding of the 
biological properties of NPs at a cellular level is vital (Lee et al., 2007;  Zhang et al., 2008a).  
 
Of particular interest to this project are NPs commonly used in commercial sunscreens, i.e. 
ZnO and TiO2 NPs that combine broad-spectrum UV filtering with transparency to visible 
light. The public perception of safety concerns regarding nanosunscreens has been promoted 
by certain community organizations, in contrast to the consensus of scientific research, which 
now indicates that NPs used in sunscreens do not readily penetrate beyond the skin’s stratum 
corneum (Elder et al., 2009;  Sadrieh et al., 2010;  Zvyagin et al., 2008). However, there is 
some evidence that a very small amount of Zn does become bioavailable from the application 
of sunscreens containing ZnO, irrespective of whether it is in bulk or NP form (Gulson et al., 
2010). Moreover, as the epidermis of infants and the elderly is much thinner than adults, NPs 
from sunscreen may be more likely to penetrate into their stratum corneum. With damaged 
skin, including that from UV exposure before nano-sunscreen application, NPs may 
potentially penetrate the outermost dead-cell layer of the epidermis and encounter living 
tissue (Zhang et al., 2008b). Although many sunscreens are formulated to remain on the skin 
surface, many dual sunscreen/moisturizer products use excipients that increase skin 
permeability to deliver active ingredients such as vitamins.  
 
As previously described in chapter 1, if NPs do reach living tissue, they are likely to 
encounter structural cells of the skin, as well as effector cells of the immune system. The 
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active scavenging of debris and foreign material by phagocytic immune cells mean that they 
effectively concentrate NPs and are likely to receive a higher level of exposure than other cell 
types. Thus a detailed investigation of the effects of ZnO NPs on the function of such 
immune cells is important in understanding the safe use of these nanomaterials.  
 
Zinc is an essential mineral nutrient involved in over 200 enzymes in the body, and is the 
second most abundant transition metal, after iron (Wapnir, 1990). It has roles in the structure 
and function of enzymes, transcription factors, hormonal receptor sites, and biological 
membranes (Hambidge and Krebs, 2007). Zn also plays a crucial part in signal transduction, 
gene expression, and regulation of apoptosis (Hambidge and Krebs, 2007;  Truong-Tran et al., 
2001). Deficiency of Zn affects around 25% of the world’s population and can result in food 
malabsorption syndromes, chronic liver disease, chronic renal disease, sickle cell disease, 
diabetes, malignancy, and other chronic illnesses (Prasad, 2003). However, a large excess of 
Zn has been reported to lead to pathologies, such as copper deficiency (Fosmire, 1990), 
development of prostate cancer (Leitzmann et al., 2003) and immunosuppression (Rink and 
Gabriel, 2000).  
 
Some studies have reported that Zn
2+
 released from ZnO NPs is at least partially related to 
their cytotoxic potential (Sasidharan et al., 2011;  Xia et al., 2011), as detailed previously in 
Section 1.2.4. Muller and coworkers also demonstrated that ZnO nanowire-induced 
cytotoxicity in human monocytes and macrophages resulted from pH triggered, intracellular 
release of ionic Zn
2+
, rather than the high-aspect ratio nature of the wires (Muller et al., 2010). 
Although these studies have shown a relationship between Zn
2+
 and ZnO NP-induced 
cytotoxicity, whether these parameters can be directly correlated remains unclear and, more 
importantly, it is uncertain if there is a requirement of contact or uptake of NPs. Thus, the 
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proportionate contributions to cytotoxicity by extracellular or intracellular dissolution of NPs 
(with subsequent release of Zn
2+
) is difficult to ascertain. 
 
The second key determinant to the cytotoxicity of ZnO NPs is increased ROS production that 
can result in oxidative stress, apoptosis and necrosis. ROS have been implicated in the 
cytotoxicity of ZnO NPs (Nel et al., 2006) and there is evidence that ZnO NPs can induce 
elevated levels of ROS in human and mouse immune cells (Hanley et al., 2009;  Lin et al., 
2009;  Xia et al., 2008). Importantly, ZnO itself cannot directly catalyze ROS as zinc ions 
normally only exists in the +II oxidation state and cannot undergo electron reduction in 
biological systems. However, ZnO can indirectly raise ROS production by fully occupying 
oxidative stress defense macromolecules, such as metallothionein, which is then not available 
to bind other transition metal ions, such as Fe and Cu, that are then free to catalyze Fenton-
type reactions (Chevion, 1988;  Krezel et al., 2007). Whilst it might be expected that Zn
2+
 
cytotoxicity can therefore be directly related to excess ROS production, it is important to 
consider that organelles like mitochondria also leak electrons, especially after damage, and 
can be a major source of intracellular superoxide (Musatov and Robinson, 2012). Previous 
studies have indicated that intracellular ROS generation does appear to be related to the 
cytotoxicity of ZnO NPs (Xia et al., 2006;  2008), though whether this intracellular ROS is 
the main cause of cytotoxicity of ZnO NPs, or a result of the damage caused by unbound 
intracellular Zn
2+
, remains unclear.  
 
In this section, we have addressed the relationship between ZnO NP-induced cytotoxicity, 
Zn
2+
 ion release and ROS production. We have also assessed whether the release of Zn ions 
is primarily intracellular or whether extracellular dissolution of ZnO NPs causes similar 
cellular outcomes. In addition, we have added antioxidants to the test system, to determine 
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whether mitigation of the ROS response affects cytotoxicity. Finally, we have investigated 
the effect of surface chemistry on the toxicity of ZnO NPs. To achieve these research 
objectives, we have exposed human THP-1 monocytes and macrophages for 24 hr to a broad 
concentration range of ZnO NPs, or the dialysate generated from ZnO NPs incubated in 
medium for a prior 24 hr period. We have examined the cytotoxic potential of direct and 
indirect exposure of cells to these ZnO NPs at high to extreme concentrations, and 
concurrently measured available intracellular Zn
2+
 and ROS levels. In addition, we have 
added vitamins C and E with ZnO NPs into the test system and again measured cytotoxicity 
and ROS levels. Finally, we have modified the surface of ZnO NPs with 3-
aminopropyltriethoxysilane (APTES) and polyethylene glycol (PEG) and examined its effect 
on the cytotoxicity profile of ZnO NPs.  
 
3.2 Materials and methods 
3.2.1 Particle characterization.  
ZnO NPs of 30, 80, and 200 nm, with and without a surfactant dispersant were employed as 
test NPs in this study. TiO2 anatase and rutile NPs are used as insoluble control NPs. The 
methods for particle characterization for these NPs are described in section 2.1. 
 
3.2.2 Micro X-ray fluorescence microscopy (µXFM).  
THP-1 cells were removed from culture media and immediately fixed for 2 hr in 2.5% w/v 
glutaraldehyde in 0.1M sodium dimethylarsinite (cacodylate) in 2 mM CaCl2, pH adjusted 
with HCl to 7.3–7.4. Cells were subsequently washed in 2 mM CaCl2 and 0.1 M sodium 
dimethylarsinite in distilled water for 10 min. Postfixation was carried out for 20 min in 1:1 
osmium tetroxide 2% w/v stock in 0.2 M sodium dimethylarsinite with 4 mM CaCl2, 
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resulting in a final concentration of 1% w/v osmium tetroxide in 0.1 M sodium 
dimethylarsinite with 2 mM CaCl2. The cells were then washed in 0.1 M sodium 
dimethylarsinite in 2 mM CaCl2 and then in distilled water for 10 min to remove excess 
osmium tetroxide.  
 
The elemental distribution was mapped using a Fresnel zone-plate scanning x-ray 
fluorescence microprobe at the Australian Synchrotron XFM beamline (0). With this 
instrument probe size, the resolution and elemental sensitivity can be traded off against one-
another, and in this case the resolution was around 350 nm (x) by 250 nm (y). An incident 
beam of 10 keV X-rays was used to induce K-shell ionization of elements with atomic 
numbers below 30 (Z ≤ Zn). The specimen was oriented normal to the incoming X-ray beam 
and scanned using an integration of 2.5 sec per scan point. A single element silicon-drift 
diode detector (Vortex, SII NanoTechnology, CA, USA) was used to detect the X-ray 
fluorescence spectrum at each pixel. Elemental maps were generated from the three 
dimensional data sets (x, y, energy) using the MAPS software suite (v1.6.5) (Vogt, 2003). 
 
3.2.3 Cell culture and cytotoxicity assays.  
THP-1 monocytes and THP-1-derived macrophages were employed in this study. The 
detailed THP-1 differentiation protocol and cell culture procedures are described in section 
2.3. NP working suspensions were mixed thoroughly by vortexing and inversion of tubes, 
before 100 μL of each NP working suspension was pipetted into the appropriate wells of a 
96-well plate already containing 100 μL of TCM and the relevant number of THP-1 
monocytes or macrophages. Plates were then incubated at 37°C and 5% CO2 for the desired 
period of time before being analysed for a range of endpoints, including the MTS cytotoxicity 
assay (as described in section 2.4). 
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3.2.4 Intracellular zinc ion measurement.  
Intracellular zinc ions were measured by zinquin ethyl ester (Biotium, CA, USA), a UV-
excitable fluorescent zinc indicator (Ex 364 nm/Em 385 nm). Cells were seeded in 96-well 
plates and incubated with ZnO NPs for 24 hr, as described above for the cell culture 
procedure. After 24 hr of co-culture with NPs, cells were washed with PBS to remove 
extracellular zinc. Cells were then incubated with 25 µM zinquin ethyl ester for 30 min in a 
dark and humidified incubator at 37°C and 5% CO2 to allow for cellular uptake. Once the 
zinquin ethyl ester is internalized, its ethyl ester group is cleaved by cytosolic esterases which 
impede its efflux across the plasma membrane. After 30 min, the cells were washed again 
with PBS to remove extracellular zinquin ethyl ester. Finally, fresh media was added and 
cells were analyzed using flow cytometry (FACS Canto II, Becton, Dickinson and Co., 
Franklin Lakes, NJ, USA). Each treatment was performed in triplicate per experiment, over 
three experiments. 
 
3.2.5 Total cell-associated zinc measurement. 
Solutions from the cell culture experiments were characterized for zinc concentration per cell 
via Inductively Coupled Plasma (ICP) Time of Flight (TOF) Mass Spectrometry (MS). Prior 
to extraction, cells were washed 3 times in cell culture media to remove extracellular NPs. 
Each well was then washed twice (2 x 200 μL) with double distilled (DD) concentrated nitric 
acid, in order to extract all material present. Each solution was then diluted with ~3 vol% DD 
nitric acid in ultra-pure (milliQ) water (15 mL). For drift correction, the internal standard Sc, 
was added to each solution (at 59 ppb, diluted from a commercial stock solution). Each 
sample solution was then filtered via a 0.45 μm nylon syringe filter to prevent blockage of the 
ICP-MS nebuliser. Solutions were then measured with an GBC Optimass 9500 ICP-TOF-MS 
instrument. A commercial stock solution of Zn was used for calibration standards (~5, 10, 30, 
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60, and 120 ppb). All standards were ionic-strength adjusted, so as to contain the same high 
concentration of nitric acid present in the samples.   
 
3.2.6 NP solubility.  
The solubility of ZnO NPs in medium with 10% v/v FBS was determined by dialysis. A 
dialysis tube (benzoylated cellulose to reduce pore size, 12 kDa size cutoff, 9 mm flat width, 
Sigma Aldrich D-2272), filled with medium/FBS (5 mL) was inserted into cell culture media 
(RPMI-1640, 20 mL) at 37°C containing ZnO NPs. After dialysis for 24 hr, dialysates were 
added to the cell culture system, and the cytotoxicity following a 24 hr exposure period was 
measured as a loss of cell viability by the MTS assay. Each treatment was performed in 
triplicate per experiment, over three experiments. 
 
3.2.7 Intracellular ROS generation. 
Both intracellular peroxide and mitochondrial superoxide generation of NP-exposed cells 
were measured in this study. In this section, intracellular ROS was measured after the 24 hr 
exposure time-point, as described in section 2.5. 
 
3.2.8 Mitigation of superoxide generation.  
In this study, the lipophilic antioxidant vitamin E (α-tocopherol) or the hydrophilic 
antioxidant vitamin C (L-ascorbic acid) were co-exposed with ZnO 30 nm NPs to THP-1 
monocytes to determine whether they could mitigate superoxide generation in this system. 
For each antioxidant, two different concentrations (0.1 and 10 µg/mL) were examined in this 
study. The effect of antioxidants was investigated by measurement of superoxide generation 
(section 3.2.7) and cytotoxicity (section 3.2.3). 
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3.2.9 Surface modification of ZnO NPs. 
Surface-modified ZnO NPs were synthesized according to the literature, with minor 
alterations to the procedure (Grasset et al., 2003). A typical procedure for the synthesis of 3-
aminopropyltriethoxysilane (APTES) modified ZnO 30 NPs (denoted as “APTES@ZnO” 
NPs) is given as follows. Briefly, 2 g ZnO 30 NPs were dispersed into 200 mL anhydrous 
toluene under nitrogen gas flow in a 250 mL round bottom flask. After 1 hr of stirring 
magnetically, 1 mL APTES was added under nitrogen protection. The mixture was refluxed 
under a nitrogen gas flow for a further 15 hr. Finally, after cooling down to room temperature, 
the reactant was centrifuged (2,500 g) and washed 3 times using fresh toluene and anhydrous 
ethanol to remove the excess APTES, then dried in a vacuum oven overnight to remove the 
solvent.  
 
PEGylated ZnO NPs (denoted as “PEG@ZnO” NPs) were synthesized by a similar 
procedure, whereby PEGylated silane was used instead of APTES. Specifically, PEGylated 
silane was synthesized following a procedure from the literature, with some alterations (He et 
al., 2010). Firstly, 0.8 mL (4 mmol) of tetraethyleneglycol monomethyl ester was dissolved 
into 10 mL dry pyridine with vigorous stirring under nitrogen gas flow at 70°C. After stirring 
for 1 hr, 1 mL (4 mmol) of 3-(triethoxysilyl) propyl isocyanate (TESPIC) was added 
dropwise into the mixture. The reaction was kept for 24 hr at 70°C under the protection of a 
nitrogen atmosphere. After that, the solvent was evaporated under vacuum to afford the 
product as a light yellow liquid. 
 
3.2.10 Biological effect of surface-modified ZnO NPs on THP-1 cell lines. 
To test the biological effect of surface-modified ZnO NPs, we employed THP-1 cell lines as 
candidate cells. In this study, we investigated the biological effects of surface-modified ZnO 
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NPs by examining the cytotoxicity, intracellular zinc ions and uptake of these NPs on THP-1 
monocytes and macrophages. The cytotoxicity of surface modified ZnO NPs was measured 
by MTS assay, which is described in section 2.4.2. Intracellular zinc ions were measured by 
zinquin ethyl ester, detail of the assay method is described in section 3.2.4. The uptake of 
ZnO NPs was investigated by measuring the total cell-associated zinc using ICP-MS, detail 
of the assay method is described in section 3.2.5. 
 
3.2.11 Statistics.  
Data were presented as mean ± standard error of mean (SEM) and was analysed using two-
way ANOVA and Bonferroni post hoc test (Prism 5.0, GraphPad Software, La Jolla, CA, 
USA), with a p value < 0.05 considered significant. 
 
3.3 Results 
3.3.1 Particle characterisation.  
Zinc oxide NPs with a diameter of 30, 80 and 200 nm, in both untreated and surfactant-
dispersed forms (designated as “ZnO” or “sZnO”, respectively), as well as TiO2, as anatase 
and rutile NPs, were mainly employed in this study. The primary particle size in water was 
assessed using dynamic light scattering (DLS, Table 3.1). Primary particle size was also 
measured via DLS in cell culture media, but interference from suspended protein particulates 
confounded the results. To measure the agglomerate size, the disc centrifugation technique 
was used instead. The surface areas for primary particles and agglomerates were also 
calculated assuming a spherical agglomerate distribution. Values for these data are 
summarized in Table 3.1. All particles were also imaged in both water by TEM and cell 
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culture media (+10% serum) by cryo-TEM, and sample images have been collated in Figures 
3.1 and 3.2. 
 
Table 3.1 Particle characterization
*
 (Shen et al., 2013). 
Particle 
Disc Centrifuge 
Agglomerate Size    
(mean [peak half-width]) 
Agglomerate 
Surface Area 
(m
2
/g) 
Primary Particle 
Size (nm) 
Primary Particle 
Surface Area 
(m
2
/g) 
TiO2 Anatase 111 nm [55 – 209 nm] 13.62 DLS: 25  3  60  
TiO2 Rutile 229 nm [101 – 380 nm] 6.50 DLS: 34  3  44  
ZnO 30 1.33 µm [0.68 – 1.98 µm] 0.80 
DLS: 36  6  
(TEM: 25  7) 
30 
ZnO 80 1.32 µm [0.65 – 1.32 µm] 0.81 DLS: 83  8 13  
ZnO 200 1.29 µm [0.88 – 1.69 µm] 0.83 DLS: 200-500 3 
sZnO 30 75 nm [50 – 100 nm] 14.27 ** ** 
sZnO 80 90 nm [50 – 130 nm] 11.89 ** ** 
sZnO 200 460 nm [240 – 670 nm] 2.33 ** ** 
*Disc centrifuge analysis was used to measure agglomerate size of ZnO and TiO2 NPs (mean [peak half-
width]) after 24 hr exposure to cell culture media with 10% serum. Primary particle size was also determined by 
DLS for each particle in a dispersed solution in water (mean ± SEM, n=2). Surface areas were calculated 
assuming nominally spherical particles and particle agglomerates. Acknowledgement of Victoria Coleman and 
the National Measurement Institute (NMI) for assistance with disc centrifugation assay. ** Primary particle size 
for surfactant-dispersed NP is the same as for pristine material. 
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Figure 3.1 TEM images of the ZnO and TiO2 NPs used in this study (scale bar applies to all 
images). NPs were dispersed in distilled water prior to imaging (provided by Lynne 
Waddington and Andrew Hastings) (Shen et al., 2013). 
 
 
 
 
Figure 3.2 Cryo-TEM images of the ZnO and TiO2 NPs used in this study (scale bar applies 
to all images). NPs were incubated in cell culture media with 10% serum for 24 hr prior to 
imaging (provided by Lynne Waddington and Andrew Hastings) (Shen et al., 2013). 
 
3.3.2 Micro X-ray fluorescence microscopy (µXFM).  
As endogenous cellular zinc can be present throughout the cell, we used a modified ZnO 30 
nm NP that had been lattice doped with cobalt (~3.5 atom %), which is X-ray fluorescent and 
is naturally of very low abundance in cells. This modification did not alter the cytotoxicity 
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profile of the ZnO NPs to THP-1 cells (Figure 3.3). Importantly this process did not require 
the addition of an optically fluorescent tag (i.e. external modification of the NPs that may 
influence cell uptake), and thus allowed us to directly image the uptake of these, only slightly 
modified, ZnO NPs by µXFM. The µXFM elemental map of ZnO-exposed, THP-1 
differentiated macrophages (Figure 3.4) showed low levels of dispersed zinc throughout the 
cells (a co-located phosphorus map is shown to indicate the extent of the cell cytoplasm and 
nucleus). These data also showed aggregates of co-localized zinc and cobalt, indicating that 
the NPs had remained intact during intracellular uptake. Whilst only a small number of cells 
were examined, NP distributions were consistent with agglomeration in a small number of 
large vesicles in the cytoplasm. NPs were not observed to be co-located with the nucleus. 
While these images alone do not confirm internalization of the NPs, we have since 
undertaken other studies using a combination of sequential focused ion beam ablation, µXFM, 
and scanning EM that clearly indicate cytoplasmic uptake of the NPs (James et al., 2013). 
 
Figure 3.3 Cell viability of macrophages 24 hr post ZnO 30 and Co-doped ZnO 30 treatment. 
Data represents mean ± SEM of 3 experiments in quadruplicate. Nominal Co doping % 
values are shown in the key (5% nominal is ~3.5 atom % actual). There was no statistical 
difference between any of the curves as determined by two-way ANOVA with Bonferroni 
post hoc test (P>0.05) (provided by Sean O’Keefe) (Shen et al., 2013).   
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Figure 3.4 µXFM synchrotron elemental maps of ZnO NPs (doped with 3.5 atom % Co) in 
exposed THP-1 macrophages, illustrating large agglomerates of NPs associated with the cells 
after 24 h. Phosphorus (red) highlights the cytoplasm and nucleus, and zinc (blue) is present 
throughout the cell, although co-localization with cobalt (green) clearly indicates the NPs, 
which were typically associated with a small number of vesicles and not found in the nucleus. 
The co-localized image is displayed on the bottom right (in association with Bryce Feltis and 
Simon James) (Shen et al., 2013). 
 
3.3.3 Cytotoxicity profiles.  
THP-1 immune cells (monocytes and macrophages) were exposed to ZnO concentrations of 1, 
10, 25, 50, 75 and 100 µg/mL and cytotoxicity investigated after 24 hr of exposure using the 
MTS dye assay for cell viability. Figure 3.5 shows that the viability of ZnO-exposed cells 
decreased in a dose-dependent manner at >20 μg/mL for both monocytes and macrophages. 
In addition, ZnO NPs displayed similar cytotoxicity to ZnCl2. The viability data also showed 
that the cytotoxicity of ZnO NPs was size-dependent, with cytotoxicity increasing as NP size 
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decreased. To examine the effects of dispersion on cytotoxicity, each of the pristine NPs were 
formulated as surfactant-dispersed preparations (approximately 5% surfactant by weight). 
Surfactant alone did not alter cell viability up to a concentration of 100 µg/mL (data not 
shown). We observed decreased viability in THP-1 immune cells when they were exposed to 
surfactant-dispersed ZnO NPs compared with the equivalent-sized pristine ZnO NPs. These 
results were consistent with our previous findings, which demonstrated both NP size and 
dispersion dependent cytotoxic effects in this cell type (Feltis et al., 2012).  
 
 
Figure 3.5 Cell viability of human THP-1 monocytes (A) and macrophages (B) after 24 hr 
exposure to pristine or surfactant dispersed (s) ZnO NPs or ZnCl2 (zinc ion control) (mean ± 
SEM, n=3 experiments), showing that particle size and dispersion influence cytotoxicity. All 
concentrations at or below the horizontal line were highly significantly different from 
untreated control cells (p < 0.001) (Shen et al., 2013). 
 
As the solubility of ZnO NPs was a significant confounding issue in this study, we also 
employed TiO2 NPs as an insoluble control. We observed little to no change in the viability 
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(~10% reduction at the highest concentration) of THP-1 immune cells exposed to TiO2 NPs 
for 24 hr (Table 3.2), which was very low compared to the cytotoxicity observed with ZnO 
NP exposures.  
 
Table 3.2 Cell viability and relative generation of mitochondrial superoxide of human THP-1 
cells after 24 hr exposure to TiO2 NPs (insoluble NP control) (Shen et al., 2013). 
Monocytes 
Dose 
(µg/mL) 
Viability  
(% of control)  
(Mean ± SEM; n=3) 
Mitochondrial superoxide level 
(% of control)  
(Mean ± SEM; n=3) 
TiO2 Anatase 10 100 ± 3 91 ± 21 
 
50 96 ± 2 94 ± 2 
 
100 92 ± 2 99 ± 2 
TiO2 Rutile 10 103 ± 2 93 ± 2 
 
50 99 ± 2 95 ± 2 
 
100 91 ± 3 98 ± 3 
Macrophages 
Dose 
(µg/mL) 
Viability  
(% of control)  
(Mean ± SEM; n=3) 
Mitochondrial superoxide level 
(% of control)  
(Mean ± SEM; n=3) 
TiO2 Anatase 10 99 ± 1 136 ± 4* 
 
50 94 ± 1 127 ± 4 
 
100 90 ± 2 128 ± 12 
TiO2 Rutile 10 101 ± 2 141 ± 8** 
 
50 97 ± 1 124 ± 9 
 
100 89 ± 3 129 ± 16 
Asterisks denote concentrations significantly different from untreated control cells (* p < 0.05, ** p<0.01). 
 
3.3.4 Intracellular zinc ions.  
Intracellular dissolution of zinc ions from ZnO NPs was investigated using zinquin ethyl ester, 
a specific fluorescent zinc indicator (Coyle et al., 1994). In this experiment, THP-1 immune 
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cells were exposed to ZnO NPs at concentrations of 10, 50, and 100 µg/mL and intracellular 
zinc ion levels were measured after 24 hr of exposure by flow cytometry. The available 
intracellular zinc levels in monocytes increased with increasing ZnO NP concentrations 
(Figure 3.6). Direct binding of zinquin to the ZnO NPs was also assessed by flow cytometery, 
with no fluorescent signal being observed (Figure 3.7). Therefore, it appears that zinquin is 
able to distinguish between zinc in NP form and other forms of more readily available zinc. 
 
 
 
Figure 3.6 Intracellular zinc ion levels in THP-1 monocytes (A) and macrophages (B) after 
24 hr exposure to ZnO NPs and ZnCl2 (zinc ion control), relative to the endogenous available 
zinc in untreated (control) cells (mean ± SEM, n=3 experiments). Available intracellular zinc 
was greater with increasing NP concentration and smaller particle size. Asterisks denote 
concentrations that were significantly different from untreated control cells (** p < 0.01, *** 
p<0.001) (Shen et al., 2013). 
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Figure 3.7 Zinquin fluorescence induced by ZnO NPs (100 µg/mL) alone or with exposed 
THP-1 monocytes, compared to the endogenous available zinc in untreated (control) cells 
(mean ± SEM, n=3 experiments) (Shen et al., 2013). 
 
A strong correlation (R² = 0.945, p<0.0001) between viability and intracellular zinc levels 
was observed across all ZnO NP formulations and concentrations for ZnO NP exposed 
monocytes (Figure 3.8A). A similar correlation was also observed in macrophages (R² = 
0.554, p = 0.0055), though it was slightly weaker, presumably as a result of the complexity 
that these highly phagocytic cells add to the system (Figure 3.9A). 
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Figure 3.8 Intercorrelation of cell viability, intracellular zinc and superoxide levels in ZnO 
NPs (and ZnCl2 as the zinc ion control) treated THP-1 monocytes. Strong relationships were 
observed between all of these factors, regardless of specific NP size or dispersion (Shen et al., 
2013). 
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Figure 3.9 Intercorrelation of cell viability, intracellular zinc and superoxide levels in ZnO 
NPs (and ZnCl2 as the zinc ion control) treated THP-1 macrophages (Shen et al., 2013). 
 
3.3.5 Total cell-associated zinc. 
The total cell-associated zinc was assessed by ICP-MS, which showed very high zinc levels 
(Table 3.3), particularly at the highest ZnO NP concentration (100 μg/mL). This large excess 
of zinc suggests that most of the cell-associated ZnO NPs were most likely undissolved. The 
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total cell-associated zinc levels from sZnO NP- and ZnCl2-exposed cells were near control 
levels, suggesting that the uptake of these more highly dispersed materials was substantially 
less.   
 
Table 3.3 ICP-MS analysis of total cell-associated Zn levels
*
 (Shen et al., 2013). 
Particle and 
Concentration 
Mass of zinc 
(pg/cell) in 
Macrophages 
Estimated no. of 
nanoparticles/cell in 
Macrophages 
Mass of zinc  
(pg/cell) in  
Monocytes 
Estimated no. of 
nanoparticles/cell 
in Monocytes 
ZnO 30; 100 µg/mL 99.4 ± 2.8 1,244,575 22.9 ± 3.3 285,249 
ZnO 30; 50 µg/mL 24.6 ± 2.5 300,548 5.1 ± 0.6 61,247 
ZnO 30; 10 µg/mL 1.3 ± 0.1 6,614 0.3 ± 0.0 236 
sZnO 30; 100 µg/mL 1.8 ± 0.1 13,145 1.9 ± 0.0 21,478 
sZnO 30; 50 µg/mL 2.1 ± 0.1 16,229 0.5 ± 0.1 3,083 
sZnO 30; 10 µg/mL 0.6 ± 0.0 0 0.2 ± 0.0 0 
ZnO 200; 100 µg/mL 74.6 ± 0.3 3,145 56.6 ± 2.8 2,398 
ZnO 200; 50 µg/mL 28.4 ± 0.3 1177 19.6 ± 0.7 825 
ZnO 200; 10 µg/mL 1.7 ± 0.1 38 0.5 ± 0.0 11 
ZnCl2; 100 µg/mL 1.0 ± 0.0 - 0.4 ± 0.0 - 
ZnCl2;  50 µg/mL 0.8 ± 0.0 - 0.4 ± 0.0 - 
ZnCl2; 10 µg/mL 0.2 ± 0.0 - 0.3 ± 0.0 - 
Control 0.8 ± 0.0 - 0.2 ± 0.0 - 
*Inductively-coupled plasma mass spectroscopy (ICP-MS) was used to measure total cell-associated Zn in 
NP-exposed cells after 24 hr. Cell populations per well were 100,000 and 175,000 for macrophages and 
monocytes, respectively. NP numbers were calculated assuming nominally spherical particles with a density of 
5.606 g/cm3, after the subtraction of control concentrations of zinc. Data are expressed as mean ± standard error 
of duplicate wells. Acknowledgement of Bryce Feltis and Vidura Jayaratne for assistance with ICP-MS. 
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3.3.6 NP solubility.  
Whilst the data above has shown that available intracellular zinc levels were highly related to 
the cytotoxicity of ZnO NPs, it was still unclear whether this Zn
2+
 mediated cytotoxicity was 
induced by intracellular or extracellular dissolution of NPs. To address this question, we 
exposed human THP-1 monocytes for 24 hr to the dialysate generated from the ZnO NPs 
with the highest surface area to volume ratio (ZnO 30 nm at 0.05–5 mg/mL) incubated in 
medium during a prior 24 hr period. Whilst we had seen that direct exposure to ZnO NPs 
induced cytotoxicity at high concentrations (Figure 3.5), the NP-free dialysates were not 
found to be cytotoxic, even when dialysates from extremely high initial ZnO NP 
concentrations (5 mg/mL) were tested (Figure 3.10). These data were consistent with our 
previous findings of a zinc precipitate that forms in biological media (Turney et al., 2012). 
The Zn ion concentration of the dialystate was also measured in this study. By the dialysis 
method, the dialystate had a Zn ion level of 2.8 μg/mL for ZnO 30 NPs at 100 µg/mL after 24 
hr incubation in cell culture media. 
 
 
Figure 3.10 Cell viability of human THP-1 monocytes after 24 hr exposure to NP-free 
dialysates from initial ZnO NP concentrations (mean ± SEM, n=3 experiments) (Shen et al., 
2013). 
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3.3.7 Intracellular ROS generation. 
The less specific ROS fluorophore that primarily detects peroxides (2’,7’-dichlorofluorescin 
diacetate, DCFDA) did not show an elevation in ROS when the immune cells were exposed 
to ZnO NPs after 24 hr (Figure 3.11). 
 
 
 
Figure 3.11 Generation of intracellular reactive oxygen (primarily peroxides by DCF) in 
THP-1 monocytes (A) and macrophages (B) treated with ZnO NPs or ZnCl2 (zinc ion control) 
(mean ± SEM, n=2 experiments) (Shen et al., 2013). 
 
Mitochondrial superoxide generation was measured using the MitoSOX
TM
 Red reagent via 
flow cytometry. These experiments showed that with increasing concentrations of pristine 
ZnO NPs, mitochondrial superoxide levels were also marginally increased in both THP-1 
monocytes and macrophages (Figure 3.12). Surfactant-dispersed ZnO NP exposed cells 
generated more mitochondrial superoxide (likely due to higher available surface area) than 
with pristine NPs at equivalent doses, while the Zn ion control (ZnCl2) induced similar 
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superoxide levels to ZnO NPs. These data exhibited a strong inverse correlation between cell 
viability and the generation of superoxide in both monocytes (R² = 0.826, p<0.0001) and 
macrophages (R² = 0.800, p<0.0001, Figures 3.8B & Figure 3.9B). In addition, a strong 
correlation was also observed between intracellular superoxide and zinc ion levels in 
monocytes (R² = 0.906, p<0.0001), with a slightly weaker correlation in macrophages (R² = 
0.640, p=0.0051) (Figures 3.8C & Figure 3.9C). Mitochondrial superoxide generation in 
THP-1 cells exposed to TiO2 NPs was slightly, though not significantly, less than untreated 
cells in monocytes and 27-36% higher in exposed macrophages, though this is still lower than 
any of the ZnO NP exposed cells (Table 3.2).   
 
 
Figure 3.12 Generation of mitochondrial superoxide by THP-1 monocytes (A) and 
macrophages (B) after 24 hr exposure to ZnO NPs and ZnCl2 (zinc ion control) (mean ± SEM, 
n=3 experiments). Similarly to intracellular zinc, superoxide was greater with increasing NP 
concentration and smaller particle size. Asterisks denote concentrations that were 
significantly different from untreated control cells (* p<0.05, ** p < 0.01, *** p<0.001) 
(Shen et al., 2013). 
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3.3.8 Mitigation of superoxide generation.  
Although intracellular superoxide generation was highly correlated to the cytotoxicity of ZnO 
NPs, it remained difficult to determine whether the observed increased intracellular 
superoxide was the cause of cytotoxicity, or just a consequence of mitochondrial membrane 
leakage, leading to cell death. As a preliminary exploration, the lipophilic antioxidant vitamin 
E (α-tocopherol) or the hydrophilic antioxidant vitamin C (L-ascorbic acid) were co-exposed 
with ZnO 30 nm NPs to cells, which showed a small decrease in cell viability within the 
tested concentration range (Figure 3.13A). In these co-exposure experiments, intracellular 
superoxide generation was slightly inhibited by both antioxidants (Figure 3.13B), but cell 
viability was not improved. Thus, while there was a strong correlation between cytotoxicity 
and reactive oxygen generation, increases in intracellular superoxide levels were not the sole 
cause of ZnO NP-induced cytotoxicity in this test system.  
 
 
Figure 3.13 Cell viability (n=2 experiments) (A) and inhibition of mitochondrial superoxide 
(n=3 experiments) (B) in human THP-1 monocytes after 24 hr exposure to ZnO 30 nm NPs 
and antioxidants (mean ± SEM). Antioxidants did not significantly improve viability, though 
they did cause a small reduction in superoxide levels. Asterisks denote concentrations that 
were significantly different from the “no antioxidant” control cells (* p<0.05, ** p < 0.01, 
*** p<0.001) (Shen et al., 2013). 
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3.3.9 Surface modification of ZnO NPs. 
The surface modification of ZnO NPs was achieved within our joint RMIT-Monash research 
group by using a grafting method through the silanization reaction between organo-siloxane 
and the hydroxyl groups on ZnO NP surfaces. Prior to biological testing, modified NPs were 
comprehensively characterized by Mingdeng Luo (Monash University). Fourier transform 
infrared (FTIR) spectra confirmed the successful silanizaton reactions between ZnO and the 
coating agents (data not shown). The capping agents were adsorbed onto the ZnO surface 
through Zn–O–Si bonds. Compared with the bare ZnO NPs, the modified ZnO NPs exhibited 
characteristic peaks of the corresponding ligands. Scanning electron microscopy (SEM) was 
applied to characterize the primary particle size and the morphology of different grafted ZnO 
NPs (Figure 3.14). Analysis of SEM images revealed monodispersed hexagonal ZnO NPs 
with a diameter of around 40 nm. Powder X-ray diffraction (XRD) spectra confirmed that the 
ZnO NPs had a hexagonal wurtzite type crystal structure, both before and after surface 
modification (Figure 3.15). Surface charges of the different ZnO NPs were characterized by 
the measurement of zeta potential in water with different pH values (Figure 3.16). Pristine 
ZnO NPs had an isoelectric point (IEP) at about 9.1, while the IEPs of PEGylated ZnO and 
amino-modified ZnO NPs were 8.2 and >10, respectively. Furthermore, all the NPs were 
positively-charged at physiological pH (7.4). The weight loss of modified ZnO NPs was 
measured by thermal gravimetric analysis (TGA). Taken together, these data indicate that 
surface modification of ZnO NPs was successfully achieved and conferred the NPs with 
different surface properties.  
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Figure 3.14 SEM images of ZnO and APTES@ZnO NPs (provided by Mingdeng Luo). 
100nm 
ZnO 
100nm 
APTES@ZnO 
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Figure 3.15 XRD patterns of bare and modified ZnO NPs (provided by Mingdeng Luo). 
 
 
Figure 3.16 Zeta potential of pristine and surface modified ZnO NPs in water with different 
pH values (provided by Mingdeng Luo). 
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3.2.10 Biological effect of surface modified ZnO NPs on THP-1 cell lines. 
The biological effects of surface modified ZnO NPs on human THP-1 monocytes and 
macrophages were compared with pristine ZnO NPs, by examining the cytotoxicity, 
intracellular zinc ions and uptake of these NPs.  
 
The cytotoxicity of the pristine and surface modified ZnO NPs was measured by the MTS 
assay. In this study, THP-1 monocytes and macrophages were exposed to ZnO NPs at 
concentrations of 10, 50, and 100 μg/mL. As shown in Figure 3.17, all of the ZnO NPs 
showed a dose-dependent cytotoxicity. In the case of monocytes, the amino-modified ZnO 
NPs (ZnO 30 APTES) showed similar cytotoxicity as pristine NPs, while the cytotoxicity of 
PEGylated ZnO NPs was significantly less than that of pristine NPs. At high dose (50 and 
100 μg/mL) the cell viability of PEGylated ZnO NPs treated monocytes was almost twice 
that following treatment with pristine NPs. In the case of macrophages, all ZnO NPs were not 
cytotoxic at the lowest dose (10 μg/mL). At 50 μg/mL, ZnO 30 APTES had slightly less 
cytotoxicity compared with pristine NPs, while PEGylated ZnO NPs showed markedly 
reduced cytotoxicity. At the highest dose (100 μg/mL), all NP-exposed macrophages showed 
very low cell viability. This is mainly due to the phagocytic properties of macrophages, which 
make it more sensitive than monocytes.  
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Figure 3.17 Cell viability of human THP-1 monocytes (A) and macrophages (B) after 24 hr 
exposure to pristine or surface modified ZnO NPs (mean ± SEM, n=3 experiments). 
 
The intracellular zinc ion levels of cells exposed to pristine and surface modified ZnO NPs 
was measured by zinquin ethyl ester. The available intracellular zinc ions in both monocytes 
and macrophages increased gradually with increasing doses of ZnO NPs (Figure 3.18). More 
interestingly, at doses of 10 and 50 μg/mL cells exposed to PEGylated ZnO NPs showed the 
lowest levels of intracellular Zn ions compared to cells exposed to either pristine NPs or 
APTES modified ZnO NPs. At the highest concentration of 100 μg/mL, all ZnO NP types 
caused very high levels of intracellular Zn ions. 
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Figure 3.18 Intracellular zinc ion levels in THP-1 monocytes (A) and macrophages (B) after 
24 hr exposure to pristine or surface modified ZnO NPs (mean ± SEM, n=3 experiments). 
 
The uptake of ZnO NPs was investigated by measuring the total cell-associated zinc using 
ICP-MS (Table 3.4). We can see that a high level of zinc was present in all NP-exposed cells 
at the NP concentration investigated (50 μg/mL). The total cell-associated zinc in 
macrophages was about twice as much as that in monocytes. What is more, the total Zn from 
cells exposed to PEGylated ZnO NPs was much less compared to pristine and APTES-coated 
ZnO NPs, suggesting that the uptake of PEGylated ZnO NPs was significantly reduced by the 
PEG coating. 
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Table 3.4 Total cell-associated Zn concentrations determined by ICP-MS (with assistance by 
Mingdeng Luo). 
Material and 
concentration 
Mass of zinc in monocytes 
(pg/cell
a
) 
Mass of zinc in macrophages 
(pg/cell
a
) 
Untreated cells n.d.
b
 n.d.
b
 
ZnO; 50 μg/mL 15.87±0.42 25.33±2.84 
ZnO@APTES; 50 μg/mL 15.42±2.59 29.93±3.53 
ZnO@PEG; 50 μg/mL 0.98±0.11 1.77±0.08 
a Cell populations per well were 100,000 both for monocytes and macrophages.  
b The concentration of zinc in untreated cells was below the instrument detection limit. 
 
3.4 Discussion 
The currently understood paradigm for ZnO NP cytotoxicity is that in mammalian immune 
cells, ZnO NPs undergo endocytosis into the cells, dissolve into bioavailable zinc and 
increase oxidative stress, which then causes cytotoxicity (Figure 3.19). This study has 
identified that the relationship between these factors can be quantified, and a strong 
intercorrelation exists between intracellular zinc, oxidative stress (generated specifically from 
mitochondria) and cytotoxicity. In addition, extracellular dissolution of ZnO NPs in cell 
culture media has been shown not to be sufficient to cause cytotoxicity, indicating a lack of 
soluble bioavailable zinc within the cell culture environment. Finally, intracellular ROS, 
whilst strongly related to cytotoxicity, can also be modulated by antioxidant treatment 
without altering the cell viability – suggesting the standing premise that “ROS induces 
cytotoxicity” may be an oversimplification of a more complex series of events.  
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Figure 3.19 Scheme describing the mechanism of the cytotoxicity of ZnO NPs (Shen et al., 
2013). 
 
This study has employed high concentrations of ZnO NPs, and although similar concentration 
ranges are typically used in in vitro studies (Muller et al., 2010;  Xia et al., 2008), it is always 
important to note that these are not likely to be encountered in most in vivo exposure 
scenarios. However, such high concentrations are required to provide sufficient contrast for 
dose-response effects suitable for mechanistic studies, in order to elucidate the structure-
activity relationships, which in this case are likely to still apply at lower in vivo doses.  
 
The dual label µXFM technique, using a combination of the Co and Zn X-ray fluorescent 
signals, allowed for direct visualization of intact NPs without needing to modify surface 
chemistry with fluorescent labels or other tags. As zinc is an essential element for cellular 
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processes, background zinc will affect the observations, particularly in the nucleus. Therefore, 
we employed cobalt-doped (3.5 atom %) 30 nm zinc oxide NPs that were tested and showed 
no altered biological activity. Cobalt is also almost absent from the cytosol and therefore 
represents a cleaner signal for NP localization. Although this method alone did not 
specifically identify their intracellular location, it has been combined with other techniques, 
such as tomography or ion-beam ablation, to explore the intracellular localization of the 
particles (James et al., 2013). The most notable finding from this work was that NPs were not 
observed in the nucleus. Alternate imaging techniques like scanning a cell via TEM could 
potentially provide similar findings, although the synchrotron technique may also allow for 
quantitation of larger numbers of cells.  
 
Whilst the present study showed strong correlations between cytotoxicity and zinc ion levels, 
it was also necessary to control for the possibility that particle size effects were not the result 
of dissolution of the material. Although titania is a very different material to ZnO, the TiO2 
NPs were formulated at very similar sizes to the smallest ZnO NP used in this study, and are 
also of very low solubility and bioactivity. Thus, had there been intracellular NP effects that 
were based solely on NP size and not the chemical reactivity of the material, the presence of 
TiO2 NPs of similar size would act as a control. Additionally, TiO2 NPs are also widely 
formulated in sunscreens and there is always some interest in comparing these two 
nanomaterials. We have also previously observed TiO2 NP uptake by immune cells via 
µXFM (data not shown), but the cytotoxicity of TiO2 NPs was much less than ZnO NPs. At 
the highest test concentration (100 µg/mL), the majority of cells exposed to ZnO 30 nm were 
killed after a 24 hr exposure (viability = 20%), whereas the TiO2 NPs at the same 
concentration had very little effect (viability = 90%, Table 3.2). Whilst there are expected to 
be some differences in uptake, the majority of the differences in cytotoxicity are likely due to 
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the large solubility differences between TiO2 and ZnO NPs, the former of which are much 
more stable in the mildly acidic pH conditions present in the intracellular endosome (Kocbek 
et al., 2010).  
 
NP solubility in general can be quite variable and dependent on the source material, ZnO NPs 
in particular are quite unstable at both high and low pH (Zhou et al., 2006). As dissolution of 
ZnO NPs and the subsequent release of Zn in some reactive form play such an important role 
in the cytotoxicity of ZnO NPs, we might have expected the extracellular dissolution to be 
more important than what was observed in this study. This lack of effect from soluble, 
extracellular zinc can be explained by some recent work, where our research group has 
shown that soluble zinc, when exposed to cell culture media and serum, rapidly forms a 
poorly soluble, amorphous zinc-carbonate-phosphate nanosized precipitate (Turney et al., 
2012). It may be that this precipitation effectively protects the cells from being exposed to 
cytotoxic concentrations of extracellular soluble zinc, as demonstrated in our dialysis 
experiment where this precipitate was presumably too large to pass through the dialysis 
membrane. This also raises the possibility of secondary nanomaterials formed from 
dissolving zinc containing materials under such circumstances. In the lower pH conditions 
present in some intracellular microenvironments, the dissolution of ZnO NPs will be much 
faster, resulting in a higher concentration of bioavailable zinc. It has not yet been established 
whether these zinc precipitates can form under cytosolic conditions. Cellular organelles such 
as the early endosome (pH 6.3), late endosome (pH 5.5) and lysosome (pH is 4.7) (Casey et 
al., 2010) are at progressively lower pH levels, and it may be that the specific uptake pathway 
the NPs ultimately take greatly influences their intracellular stability. Indeed, some groups 
have suggested that the surface structure of the NP might be critical in selecting these 
pathways (Lundqvist et al., 2008).  
 87 
 
 
Measurement of total cell-associated zinc by ICP-MS yielded significantly different results to 
quantifying available intracellular zinc with a specific zinc ion fluorophore. As the ICP-MS 
measurement assesses total zinc from intracellular NP agglomerates, and also from 
agglomerates partially phagocytosed or attached to the outside of the cell, the measured zinc 
levels were very high (Table 3.3). From these data, free zinc levels (measured by zinquin, 
Figure 3.6) were similar between the ZnO 30 and sZnO 30 samples, yet total zinc levels 
(measured by ICP-MS) was vastly higher in the ZnO 30 sample, despite the sZnO 30 samples 
being only slightly more cytotoxic than the ZnO 30 NPs. This suggests only a small portion 
of the large agglomerates present in the ZnO 30 samples (Table 3.1) were actually dissolved 
intracellularly. In contrast, total zinc levels of dispersed ZnO and ZnCl2 exposed cells were 
very low, suggesting that the total amount of these materials associated with the cells was 
much less, and the intracellular dissolution was more complete, with very little “unavailable” 
(agglomerated) zinc being detected. These data also showed the expected differences in 
uptake efficiency between the THP-1 monocytes and the more phagocytic macrophages, with 
the latter containing approximately twice as much total zinc.  
 
We have shown that the cytotoxicity of ZnO NPs is highly related with the intracellular zinc 
ion release. As long as the ZnO NPs enter the cell, it is difficult to prevent them from 
dissolving due to the intrinsic properties of both NPs and intracellular fluid, which means that 
reducing the cytotoxicity of NPs by controlling their dissolution inside cells is difficult. 
Nevertheless, efforts have been made to reduce the dissolution of ZnO NPs by iron doping, 
which further reduced the cytotoxicity of ZnO NPs (Xia et al., 2011). Although the iron in 
the doped ZnO NPs slowed the dissolution rate, it did not alter the uptake fate of such NPs. 
Therefore this approach is not an ideal methodology for the safe design of engineered 
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nanomaterials (Nel et al., 2006). However, if we could decrease the uptake of NPs, it would 
reduce the cytotoxicity much more effectively. As NPs are taken up by the cell with a protein 
corona (Dawson et al., 2009), if the formation of the protein corona is inhibited or reduced, it 
would be possible to reduce the overall cellular uptake of NPs. It was recently reported that 
the PEGylation of NPs is very effective in inhibiting the nonspecific binding of NPs to blood 
proteins and macrophages (Karakoti et al., 2011). In this study, we also showed that 
modification of the surface of ZnO 30 NPs with a PEG, but not APTES, coating successfully 
reduced the uptake of ZnO NPs, which resulted in reduced cytotoxicity of ZnO NPs. In 
addition, ZnO@APTES can bind a greater quantity of protein, which is attributed to its 
highly positively-charged aminated surface. It may be that the decreased protein binding of 
PEGylated ZnO NPs inhibits the formation of its protein corona, which then decreases the 
uptake of such NPs into cells. 
 
ROS is also considered to be a very important factor for the cytotoxicity of ZnO NPs and 
numerous studies have reported that intracellular ROS generation has at least some role in 
cell death induced by ZnO NPs (Song et al., 2010;  Xia et al., 2006). As mitochondria are a 
major intracellular source of ROS, MitoSOX
TM
 Red was employed to measure the 
mitochondrial superoxide levels in our in vitro cell system. In this study, DCFDA were also 
employed to detect the intracellular peroxide, however no elevation in peroxide was observed 
when these cells were exposed to ZnO NPs (Figure 3.13). The strong relationship between 
cytotoxicity of ZnO NPs and intracellular superoxide in the current in vitro cell system shows 
a mechanistic link, but does not necessarily imply causality. There are two primary possible 
orientations for the “cause and effect” relationship between ROS and cytotoxicity, neither of 
which are mutually exclusive: The first is that the increased intracellular superoxide results in 
damage to organelles, which eventually fail and cause cytotoxicity. Conversely, the increased 
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intracellular superoxide arises from mitochondrial membrane damage, leading to electron 
leakage and subsequent ROS. In this scenario the failure of the mitochondria would be 
instigated by displacement of vital co-factors with zinc ions. However, we also cannot 
discount the possibility that both of these processes occur simultaneously within the cells.  
 
The introduction of the two antioxidants vitamin E (α-tocopherol), vitamin C (L-ascorbic acid) 
into our in vitro co-exposure cell system was an attempt to ascertain the proportionate 
contribution of ROS to cytotoxicity. These two antioxidants were chosen for their different 
properties: α-tocopherol is a lipophilic antioxidant, which can quench lipid radicals; and L-
ascorbic acid is water soluble, which mostly quenches the free radicals in aqueous phases. 
The results (Figure 3.12B) indicated that both antioxidants slightly suppress ROS, but do not 
affect cytotoxicity, which at the very least suggests that some of the observed intracellular 
superoxide levels were not responsible for ZnO NP-induced cytotoxicity in this test system. It 
is proposed that zinc displacement of redox-active metal ions (the primary source of ROS 
generation by zinc) also causes dysfunction in systems that are dependent on these other 
metals as co-factors. It has also been observed in other studies that ZnO NPs can cause 
lysosome destabilization in exposed THP-1 macrophages (Cho et al., 2011), or that reactive 
forms of intracellular Zn
2+
 from the dissolution of ZnO NPs can cause Zn
2+ 
dependent protein 
activity disequilibrium (Cho et al., 2012) both of which could reduce cell viability. It may 
have been possible to suppress ROS further by using higher concentrations of antioxidants, 
but the concentrations we employed already showed a small decrease in cell viability, and 
higher doses would have confounded the interpretation of cytotoxicity data due to the direct 
effect of the antioxidants on the cells. Furthermore, poor penetration of the antioxidants into 
the cells is unlikely to explain the slight effect of these treatments, as vitamin E partitions into 
the cell membrane compartment and vitamin C is readily taken up by immune cells. 
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In this section, we have demonstrated that the intracellular dissolution of ZnO NPs, with 
subsequent release of bioavailable Zn, is the main determinant of cytotoxicity for ZnO NPs. 
Moreover, these factors both correlate strongly with each other and with intracellular reactive 
oxygen generation, providing strong evidence that both of these determinants are required for 
ZnO NP cytotoxicity in human immune cells.  
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Chapter 4. Comparison of UVA-induced ROS 
and sunscreen NP-generated ROS in human 
immune cells 
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4.1 Introduction 
UV-induced ROS have been implicated in photocarcinogenesis and skin ageing (Scharffetter-
Kochanek et al., 1997). This is because UV-induced ROS can induce DNA damage that, if 
unrepaired, can lead to carcinogenesis (Ichihashi et al., 2003). Such DNA damage includes 
single- and/or double-strand DNA breaks, base modifications (e.g. formation of 8-
hydroxydeoxyguanosine (8-OHdG) and other oxidative products) and DNA cross-links 
(Ichihashi et al., 2003). Sunscreens contain UV attenuators, such as organic chemical and/or 
physical UV filters, which can prevent all forms of damage from UV irradiation. However, it 
has been reported that organic sunscreen UV filters can actually enhance UV-induced ROS 
once they penetrate the epidermis (Hanson, et al., 2006).  
 
In recent years, the effective broad-spectrum UV attenuation properties of ZnO and TiO2 NPs 
have made them attractive as active components in sunscreens and other personal care 
products. While organic sunscreens generally absorb UV light more effectively in the UVB 
range, only a few are able to absorb UVA. The broadest UVA attenuation is achieved with 
avobenzone, but this compound tends to break down on exposure to UV light and also has 
potential to be photo-allergenic (Paris, et al., 2009). In contrast, ZnO possesses stable broad-
spectrum UV filtering capabilities and is an attractive alternative to the less photo-stable 
avobenzone. Compared to chemical sunscreens, physical sunscreens do not break down under 
UV light and are therefore potentially longer-acting. In addition, the transparent properties of 
NP sunscreens make these products more aesthetically pleasing than the opaque formulations 
containing bulk particle-sized inorganic UV-filters. 
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As the use of NP compounds in sunscreens increases, so has public concern about their safety. 
One of the primary concerns raised about NPs is their potential to generate ROS, particularly 
when exposed to UV light (FoE, 2013). It is important to note that similar NPs are also well-
known photocatalysts used in industry, which can produce a variety of ROS for an extended 
period under certain conditions (Barker, et al., 2008). Furthermore, the high surface area 
properties of NPs can also increase the rate of generation of ROS. As previously discussed in 
section 1.4.3.3, elevated levels of mitochondrial superoxide following in vitro exposure to 
ZnO NPs has been confirmed in both mouse immune cell lines and human lung epithelial 
cells (Xia et al., 2006; Xia et al., 2008). In Braydich-Stolle’s study (Braydich-Stolle et al., 
2009), cytotoxicity profiling of TiO2 NPs in a mouse keratinocyte cell line showed that rutile 
TiO2 NPs initiated apoptosis through formation of ROS. Although there are numerous 
studies investigating ROS production by ZnO and TiO2 NPs (Braydich-Stolle et al., 2009; 
Hanley et al., 2009; Lin et al., 2009; Nel, et al., 2006; Xia et al., 2006; Xia et al., 2008), there 
is currently a paucity of studies that investigate cellular ROS generation in the presence of 
both sunscreen NPs and UV irradiation. As these materials are used in sunscreens, UV co-
exposure is certain, and thus it is vital to investigate ROS generation in cells co-exposed to 
both NPs and UV, rather than solely investigate ROS generation from NP exposure alone. 
 
It is important to consider the most appropriate form of UV irradiation for potential 
interactions with NP exposure in the biological test system. As described in section 1.3.3, 
UVC is usually not biologically relevant, except for exposure from industrial processes, such 
as arc welding and microbial photosterilization. The higher energy of UVB causes more 
overall direct cellular damage than UVA, but the shorter UVB wavelengths only penetrate 
into the epidermis. However, UVA can penetrate through to the dermis and interact with cells 
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of the immune system and is the major contributor to sunlight’s immunosuppressive effects 
(Halliday, et al., 2011).  
 
There is strong evidence (detailed in section 1.2.3.2) that there is negligible dermal 
penetration of intact metal oxide NPs past the outermost dead cell layer of the strata corneum 
(Gulson et al., 2010). However, any intact particles that do penetrate the skin are most likely 
to be scavenged by phagocytic immune cells present in the dermis and peripheral vasculature, 
such as macrophages and their monocytic precursors. Consequently, it was stated in chapter 3 
that there is a potential for these cell types to be exposed to a higher intracellular 
concentration of sunscreen NPs with concurrent UVA exposure. Therefore, in this study we 
have co-exposed human THP-1 monocyte-like cells to both UVA and metal oxide NPs, and 
assessed ROS generation – specifically intracellular peroxide and mitochondrial superoxide 
levels. We examined ROS generation in monocytes rather than macrophages because 
although both cell types phagocytose NPs, the lower basal ROS activity in monocytes (Feltis 
et al., 2012; Shen et al., 2013) facilitated the direct comparison of the individual effects of 
UVA and NP exposure on ROS generation with the effects of UVA and NP co-exposure. We 
also assessed the time course of intracellular ROS generation under these exposure conditions 
in order to evaluate the relative contribution and impact of UVA-induced ROS compared 
with sunscreen NP-generated ROS. 
 
4.2. Materials and methods 
4.2.1 Materials.  
ZnO NPs with primary particle diameters of 30 and 200 nm, with and without surfactant 
dispersant (Orotan 731 DP) were used in this study. Anatase TiO2 (25 nm) and rutile TiO2 
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(34 nm) NPs were kindly provided by CSIRO, Clayton, Australia. Full physical 
characterization methods and results for these materials are described in sections 2.1 and 
3.3.1. 
 
4.2.2 Cell culture, UV irradiation and cytotoxicity assays.  
THP-1 monocytes were used in this study. The particle preparation for addition to the test 
system is described in section 2.2, while the THP-1 cell culture and in vitro NP exposure 
methods are described in section 2.3.1. Immediately following the addition of NPs, the cells 
were exposed to UVA radiation (6.7 J/cm
2
) using a solar simulator (Vilber Lourmat, Marne-
la-Vallee, France). Control groups included wells containing cells without NPs, and with 
either UVA irradiation or no UV (sham) radiation exposure – the sham irradiation group 
controlled for potential effects of time spent outside of the incubator during the irradiation 
procedure. Following UVA irradiation, the cells were returned to the incubator. After 20 hr, 
MTS reagent was added to each well and incubated for 4 hr before being measured at 490 nm 
on a plate reader as described in section 2.4.2. Wells containing the concentration range of 
NPs and MTS reagent alone was used to control for any direct optical density effects of NPs 
by subtracting these values from the experimental readings. All treatments were performed in 
triplicate for each of three experiments. 
 
4.2.3 Intracellular ROS generation. 
In this study, ROS generation over a 22 hr time-course was measured in the forms of 
intracellular peroxide and mitochondrial superoxide by DCFDA and MitoSOX
TM
 Red, 
respectively.  
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For the DCFDA assay, fluorophore-preloaded cells were seeded into black 96-well plates at 
10
5
 cells per well, and then co-exposed with NPs and UVA, as described in sections 2.5.1 and 
4.2.2, respectively. The specific fluorescence was measured after incubation time points of 1, 
4, 8 and 22 hr. All treatments were performed in triplicate for each of three experiments. 
 
For the MitoSOX
TM
 Red assay, fluorophore-preloaded cells were seeded into standard 96-
well plates at 10
5
 cells per well, and then co-exposed with NPs and UVA, as described in 
sections 2.5.2 and 4.2.2, respectively. After incubation time points of 1, 4, 8 and 22 hr, cells 
were fixed (in -20°C ethanol) and analyzed using flow cytometry. All treatments were 
performed in triplicate for each of two experiments. 
 
4.2.4 Statistics.  
Data were presented as mean ± standard error of mean (SEM) and was analysed using two-
way ANOVA and Bonferroni post hoc test (Prism 5.0, GraphPad Software, La Jolla, CA, 
USA), with a p value < 0.05 considered significant. 
 
4.3 Results  
4.3.1 Cytotoxicity of sunscreen NPs 
The viability of THP-1 monocytes 24 hr after exposure to UVA dose was unchanged and was 
103.5 ± 1.7%, compared to the viability in untreated cells of 100.0 ± 2.2% (n=3 experiments). 
When these cells were co-exposed to both UVA and sunscreen NPs (Figure 4.1), the cell 
viability after 24 hr was not significantly altered from exposure to NPs alone (Figure 3.5A), 
which indicates that the UVA dose used in this study is not directly cytotoxic.  
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Figure 4.1 Cell viability of human THP-1 monocytes after 24 hr exposure to sunscreen NPs, 
following initial co-exposure to 6.7 J/cm
2
 UVA (mean ± SEM, n=3 experiments). All 
concentrations at or below the horizontal line were highly significantly different from control 
cells receiving UVA irradiation alone (p < 0.001). 
 
4.3.2. Peroxide generation.  
We observed that UVA exposure induced high levels of intracellular peroxide, i.e. at 1 hr the 
peroxide levels were 7-fold higher than that of sham-irradiated control (Figure 4.2). 
Comparing peroxide generation at each time point to that of the sham control at 1 hr, we 
observed that UVA-induced peroxide generation steadily increased (although this did not 
reach statistical significance; p=0.18) over the 22 hr time period to reach 8.5-fold (Figure 
4.2A). We also saw that a comparison of the peroxide generation at each time point with its 
respective sham control at that same time point, exhibited an apparent decrease in the relative 
UVA-induced peroxide generation over time (Figure 4.2B).  
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Figure 4.2 Generation of intracellular peroxide by THP-1 monocytes over the 22 hr time 
course after initial exposure to 6.7 J/cm
2
 UVA; represented as a ratio of the sham control at 1 
hr (A), and as a ratio of the respective sham control for each time point (B) (mean ± SEM, 
n=3 experiments in triplicate).  
 
In this study, we also employed hydrogen peroxide (H2O2) at 1 mM as a positive control. 
This concentration of H2O2 was chosen to generate the same level of peroxide ROS in THP-1 
monocytes as the experimental UVA dose (6.7 J/cm
2
) (Figure 4.3). The kinetic profile of 
peroxide generation over 22 hr for 1 mM H2O2 and 1.67 MED UVA was also very similar. In 
Figure 4.3A, the time course of the peroxide generation in H2O2-treated cells increased from 
7-fold at 1 hr to 8.5-fold at 22 hr compared to the 1 hr sham control. When comparing the 
peroxide generation at each time point to its respective sham control at that same time point, 
we also observed a similar decrease trend in relative UVA-induced peroxide generation over 
time (Figure 4.3B). 
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In order to compare UV-induced peroxide production to sunscreen NP-generated peroxide, 
cells were exposed to NPs both with and without UVA co-exposure. Overall, the co-exposure 
of cells to ZnO NPs and UVA showed a dose-dependent decrease in intracellular peroxide 
generation (Figure 4.4). At low and intermediate doses of the pristine ZnO 30 nm (“ZnO 30”) 
or ZnO 200 nm (“ZnO 200”) particulates that did not directly alter cell viability (i.e. 10 and 
50 µg/mL) (Figure 4.1), the intracellular peroxide levels were not significantly altered by co-
exposure with UVA. At the highest dose (100 µg/mL) these particulates decreased 
intracellular peroxide levels, but also reduced cell viability.  
 
 
Figure 4.3 Generation of intracellular peroxide by THP-1 monocytes over the 22 hr time 
course after exposure to 1 mM H2O2; represented as a ratio of the sham control at 1 hr (A), 
and as a ratio of the respective sham control for each time point (B) (mean ± SEM, n=3 
experiments in triplicate). 
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Figure 4.4 Generation of intracellular peroxide by THP-1 monocytes over the 22 hr time 
course after exposure to ZnO 30 NPs or ZnO 200 bulk particles at 10 µg/mL (A), 50 µg/mL 
(B), and 100 µg/mL (C), following initial co-exposure to 6.7 J/cm
2
 UVA; represented as a 
ratio of the sham control at 1 hr (mean ± SEM, n=3 experiments in triplicate). Time points 
marked with stars were significantly different from control cells receiving UVA irradiation 
alone (* p < 0.05, ** p < 0.01, *** p < 0.001). 
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The surfactant-dispersed ZnO 30nm (“sZnO 30”) was seen to be the most effective 
particulate, by significantly reducing the peroxide generation in UVA co-exposed monocytes 
at the intermediate dose (50 µg/mL) (Figure 4.4). At the highest dose, the sZnO NPs further 
decreased peroxide levels, but also markedly reduced cell viability. Therefore, as the lowest 
dose of sZnO 30 NPs did not alter cell viability, this slight peroxide reduction appeared to be 
mainly attributable to attenuation of UV by the particles, even in their dispersed state.  
 
In order to verify this, we measured the UV-vis spectra of the three particulates, which 
confirmed a much higher absorbance for sZnO 30 than for ZnO 30 in the UVA spectral 
wavelengths (Figure 4.5). We also found no significant differences in UVA absorbance for 
ZnO 200 and ZnO 30, which would explain why their peroxide generation profile was very 
similar (Figure 4.4). As expected, this UVA attenuation also increased with dose, which may 
account for the observed decreases in peroxide generation in THP-1 monocytes with 
increasing NP dose. Re-plotting Figure 4.4 as a ratio of the respective UVA control for each 
time point (as opposed to the 1 hr UVA control) resulted in different profiles in which 
peroxide generation did not increase over time (Figure 4.6). 
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Figure 4.5 UV-Vis spectra of ZnO and TiO2 NPs (100 µg/mL) in water (A) and RPMI-1640 
phenol red media with 10% FBS (B). 
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Figure 4.6 Generation of intracellular peroxide by THP-1 monocytes over 22 hr of exposure 
to ZnO 30 NPs or ZnO 200 bulk particles at 10 µg/mL (A), 50 µg/mL (B), and 100 µg/mL 
(C), following initial co-exposure to 6.7 J/cm
2
 UVA; represented as a ratio of the respective 
UVA-exposed control for each time point (mean ± SEM, n=3 experiments in triplicate). 
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Titania NPs, unlike ZnO, did not cause cytotoxicity in UVA-exposed cells at concentrations 
less than 1 mg/mL (Figure 4.7). The observed peroxide production profile in the TiO2-UVA 
co-exposure system was different between the crystalline forms, with anatase TiO2 NPs 
behaving substantially different from both rutile and ZnO NPs (Figure 4.8). For anatase TiO2 
NPs, the peroxide levels increased with increasing concentration (Figure 4.8). In contrast, 
rutile TiO2 behaved similarly to ZnO, with peroxide levels decreasing with increasing 
concentrations. Consequently at the highest dose of 100 µg/mL TiO2, the peroxide generated 
by cells exposed to anatase in the presence of UVA was twice that seen with rutile and UVA 
co-exposure (Figure 4.9). It should be noted that the increased generation of ROS by co-
exposure to anatase TiO2 and UVA irradiation was still insufficient to reduce cell viability, 
until extremely high concentrations were used (1 mg/mL) (Figure 4.7). In this study, we also 
measured peroxide generation without UV. In the absence of UV (Figure 4.10), we observed 
that ZnO and TiO2 alone generated much less peroxide than with UVA exposure alone 
(Figure 4.2). 
 
 
 
Figure 4.7 Cell viability of human THP-1 monocytes after 24 hr exposure to TiO2 anatase or 
rutile NPs, following initial co-exposure to 6.7 J/cm
2
 UVA (mean ± SEM, n=3 experiments 
in triplicate). Asterisks denote significant difference from control cells receiving UVA 
irradiation alone (* p < 0.05, ** p < 0.01, *** p < 0.001). 
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Figure 4.8 Generation of intracellular peroxide by THP-1 monocytes after 1 hr (A), 4 hr (B), 
8 hr (C) and 22 hr (D) exposure to ZnO or TiO2 NPs, following initial co-exposure to 6.7 
J/cm
2
 UVA; represented as a ratio of the sham control at 1 hr (mean ± SEM, n=3 experiments 
in triplicate). Asterisks denote significant difference from control cells receiving UVA 
irradiation alone (* p < 0.05, ** p < 0.01, *** p < 0.001). 
 
 
 
Figure 4.9 Generation of intracellular peroxide by THP-1 monocytes over 22 hr exposure to 
100 µg/mL TiO2, following initial co-exposure to 6.7 J/cm
2
 UVA; represented as a ratio of 
the sham control at 1 hr (mean ± SEM, n=3 experiments in triplicate). 
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4.3.3 Superoxide generation 
UVA-irradiated cells also produced high levels of mitochondrial superoxide when compared 
to negative controls (Figure 4.11). However, these increased levels of superoxide were not as 
high as peroxide levels produced under UVA, as superoxide levels were 3.3 fold higher at the 
1 hr time point compared to the 7-fold higher peroxide generation.  
 
Figure 4.10 Generation of intracellular peroxide by THP-1 monocytes over 22 hr of exposure 
to ZnO or TiO2 NPs at 10 µg/mL (A), 50 µg/mL (B), and 100 µg/mL (C); represented as a 
ratio of the sham control at 1 hr (mean ± SEM, n=3 experiments in triplicate). 
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Figure 4.11 Generation of mitochondrial superoxide by THP-1 monocytes over the 22 hr time 
course, following initial exposure to 6.7 J/cm
2
 UVA; represented as a ratio of the sham 
control at 1 hr (A), and as a ratio of the respective sham control for each time point (B) (mean 
± SEM, n=2 experiments in triplicate). 
 
 
In order to investigate the effect of UVA and NP co-exposure, we compared the 
mitochondrial superoxide generation after exposure to NPs at either equivalent cytotoxicities 
(EC50) for ZnO, or at 100 µg/mL for TiO2 NPs, with and without UVA irradiation. At 
equivalent cytotoxicity dose the oxidative stress on the cell will also be equivalent, unlike 
using the same mass based concentration, it therefore becomes possible to comparatively 
measure the sources of the oxidative stress. At the 1 hr time point, with the exception of 
anatase TiO2, the other NPs did not alter superoxide generation (Figure 4.12).  
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Figure 4.12 Generation of mitochondrial superoxide by THP-1 monocytes over 22 hr 
exposure to ZnO or TiO2 NPs, following initial co-exposure to 6.7 J/cm
2
 UVA; represented 
as a ratio of the sham control at 1 hr (mean ± SEM, n=2 experiments in triplicate). Time 
points marked with stars were significantly different from control cells receiving UVA 
irradiation alone (* p < 0.05). 
 
The kinetics for mitochondrial superoxide generation in cells with UVA and particulate co-
exposure was also different to that for peroxide generation (Figure 4.12). In TiO2-exposed 
cells, superoxide levels continued to gradually decrease over time after the initial rapid 
decline for anatase-exposed cells, whereas both ZnO 30 and sZnO 30 marginally increased 
mitochondrial superoxide levels over the same period.  
 
4.4 Discussion 
In this study, we compared the ROS generation by UVA and sunscreen NPs in human 
immune cells. The UVA component of sunlight’s UV spectrum is 95%, with the remaining 5% 
being the UVB component that causes erythema of the skin. The UVA dose used in this study 
was the UVA component of sunlight corresponding to 1.67-fold of the Minimal Erythemal 
Dose (MED) (6.7 J/cm
2
) (Kuchel, et al., 2002), which is equivalent to the UVA component of 
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approximately 30 minutes of noonday summer sun in Sydney, Australia, at 33.86°S latitude. 
This UVA dose was not directly cytotoxic to the cells in this in vitro test system. 
 
In measuring intracellular peroxide generation, we employed the ROS fluorophore DCFDA, 
which is sensitive to all forms of peroxide, including hydrogen peroxide (Halliwell, et al., 
2004). In our study, we have seen that UVA-induced peroxide generation steadily increased 
if we compared peroxide generation at each time point to that of the sham control at 1 hr. 
This fixed-time point control comparator was necessary, as we also observed that when 
comparing the peroxide generation at each time point to its respective sham control at that 
same time point, there was an apparent decrease in relative UVA-induced peroxide 
generation over time (Figure 4.2B). This experimental artefact was due to changes in the test 
to control ratios that were a product of both treatment and control peroxide levels increasing 
over time, most likely as a function of normal cellular metabolism (Poljsak et al., 2005). This 
is illustrated by the observation that the peroxide generated by the sham control increased by 
an amount very similar to the UVA-treated control (Figure 4.2A). Thus, when expressed as a 
ratio of its respective sham control, the 24 hr value is approximately half that of the value 
obtained from the 1 hr time point (Figure 4.2B), which may be a significant confounder in the 
interpretation of time course measurements using DCFDA, or indeed any measurement of 
this fluorophore at a single time point. In our study, we also observed a similar kinetic profile 
of peroxide generation over 22 hr for both 1 mM H2O2 and 1.67 MED UVA. Again, the 
increase in cellular peroxide is likely to be from normal cellular metabolism and shows that 
these DCFDA artefacts are consistent across different experimental systems for this cell type. 
 
As it is a critical component for determining the relative risk of NPs when used in sunscreen 
formulations, we have investigated ROS generation by these NPs in human THP-1 monocyte 
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immune cells following UVA co-exposure. The concentrations of ZnO NPs required in this 
system to generate detectable levels of ROS were close to the concentrations required to 
induce cytotoxicity (see Figure 4.1). Regarding peroxides, co-exposure of cells to ZnO NPs 
and UVA resulted in a dose-dependent decrease in peroxide generation. As the three ZnO 
particulates displayed different cytotoxicity profiles, the respective contributions of reduced 
viable cell number versus UVA attenuation towards the decreased peroxide generation varied 
between these particulates. The re-plotting of Figure 4.4 relative to respective UVA controls 
for each time point (Figure 4.6) showed that peroxide generation did not increase over time, 
presumably for similar reasons discussed previously for the UVA and H2O2 positive control 
data. 
 
In our study, two forms of TiO2 were also examined, one of primarily anatase crystalline 
structure and the other being primarily rutile, with similar particle sizes but different shapes. 
We showed that intracellular peroxide levels generated by anatase TiO2 NPs were much 
higher than for rutile TiO2 NPs (Figure 4.9). As the anatase phase of TiO2 is known to be 
more photocatalytic than rutile (Barker, et al., 2008), this result was not unexpected. Unlike 
most sources of rutile TiO2, the rutile material used in this study was shown to be pure by 
XRD. Given that the rutile material is known to be far less photocatalytic than anatase, the 
small amount of anatase present in typical rutile sources is presumably insufficient to induce 
biologically relevant levels of peroxide. This critical threshold for anatase levels, above 
which ROS production is no longer reduced, is obviously very important in determining the 
most desirable form of TiO2 NPs for use in sunscreens.  
 
Overall, the peroxide levels generated by UVA alone in this study was 6-7 fold higher than 
that produced by all of the particulates alone. Furthermore, co-exposure to UVA and ZnO or 
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rutile TiO2 NPs results in less peroxide generation than from UVA alone. Taken together, we 
can conclude that the levels of peroxide induced by ZnO and rutile TiO2 NPs, when 
concentrated into immune cells, are not a significant concern. High anatase TiO2 containing 
materials are an exception, as peroxide generation was enhanced in UVA and anatase NP co-
exposure compared to UVA alone. Even in this case, recent skin penetration studies suggest 
that intact sunscreen NPs do not penetrate beyond the stratum corneum of healthy skin (Elder, 
et al., 2009; Sadrieh et al., 2010; Zvyagin et al., 2008), meaning that the exposure of viable 
cells to NPs is likely to be negligible, especially as the effect of peroxides formed at or near 
the skin surface will be diffusion limited.  
 
In this study, we also investigated the mitochondrial superoxide generation. The fold 
increases in superoxide levels under UVA over the 24 hr time course were only half of those 
seen for peroxide generation. This suggests that cytoplasmic peroxide is more inducible by 
UVA than mitochondrial superoxide. Furthermore, mitochondrial superoxide levels did not 
change significantly over time, in contrast to the steady increase observed in intracellular 
peroxide levels. This suggests that normal cellular metabolism generates superoxide quite 
slowly, or that superoxide accumulation is tightly controlled in the mitochondria by 
protective antioxidant pathways (Miriyala, et al., 2011).  
 
Comparing the mitochondrial superoxide generation after co-exposure to NPs and UVA, we 
observed higher superoxide generation with anatase TiO2, in contrast to the other NPs that 
exhibited a very similar level of mitochondrial superoxide production to UVA alone (Figure 
4.12). This again reinforces that anatase TiO2 generates ROS (both cytoplasmic peroxide and 
mitochondrial superoxide) under UVA, and is therefore not an ideal UV component for use in 
sunscreen formulations.  
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Interestingly, different kinetics for mitochondrial superoxide generation were seen between 
the particulate materials, following NP and UVA co-exposure. In TiO2-exposed cells, the 
superoxide levels gradually decreased over time, whereas both ZnO NPs marginally 
increased mitochondrial superoxide levels. A possible explanation for these differences is that 
while cellular metabolism efficiently reduces mitochondrial superoxide (as illustrated by the 
decreased TiO2 signal), ZnO itself appears to induce further mitochondrial superoxide. In our 
previous studies, we have shown a strong relationship between intracellular zinc ion levels 
(elevated by dissolution of endocytosed ZnO NPs) and mitochondrial superoxide generation 
(Shen et al., 2013). Therefore these cells must cope with combined superoxide generation 
from two sources (UVA and zinc ion-mediated), leading to a net positive increase over the 22 
hr period. This marginal increase in ZnO NP-induced superoxide production strongly 
correlates with “soluble” or readily bioavailable zinc from the NPs and appears to be a more 
significant influence on the mitochondrial superoxide system over this time than UVA 
exposure. 
 
Clearly, the least reactive test material in this system was rutile TiO2, where exposed cells 
produced less cytoplasmic peroxide and mitochondrial superoxide, and showed no significant 
loss in viability. Unfortunately, TiO2 NPs of either crystalline structure do not effectively 
attenuate UVA near 400 nm and thus, unlike ZnO, rutile TiO2 is not an adequate substitute 
for chemical UVA filters such as avobenzone (Yang, et al., 2010). Whilst ZnO NPs appear to 
be more bioactive than rutile, they have several preferred characteristics for use in sunscreens. 
These include: the larger ZnO particle size further reduces skin penetration potential (Gulson 
et al., 2010; Zvyagin et al., 2008); its solubility in sweat and the acidic conditions within 
endosomes reduce its potential for persistence on skin and in the body (compared to the very 
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insoluble TiO2); that zinc as an essential metal ion with tightly-regulated mammalian 
homeostatic mechanisms (while TiO2 is not biologically essential); and the reactivity of ZnO 
in the environment (Lombi et al., 2012), reducing its potential for environmental 
biopersistence and ecotoxicity.  
 
In this section, we investigated intracellular peroxide and mitochondrial superoxide 
generation of sunscreen NP-exposed THP-1 monocytes in the presence and absence of UVA. 
We demonstrated that, with the exception of anatase TiO2, ROS generation in these human 
immune cells from sunscreen NP and UVA co-exposure is less than or equal to cellular ROS 
produced by UVA alone. In conclusion, for sunscreen formulations, photocatalytic ROS 
generation induced by ZnO NPs and TiO2 NPs of low anatase content appear to be of very 
low toxicological concern. 
  
 114 
 
 
 
 
 
 
 
Chapter 5 ZnO NPs can simultaneously 
cause pro-inflammatory and anti-inflammatory 
effects in antigen presenting cells 
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5.1 Introduction 
ZnO NPs are extensively used in our lives, especially on our skin. As ZnO has a high 
capacity for attenuating UV radiation, and also a transparent appearance in the nano-size 
form, the most common use of ZnO NPs on the skin is in the formulation of sunscreens. 
Besides these nanosunscreens, ZnO particulates are also used topically to treat skin 
conditions, such as in baby powder and barrier creams to treat diaper rashes (Zak et al., 2011). 
Nano ZnO is also regarded as being an antibacterial agent for humans and animals, which is 
an added benefit for its use in personal care products (Stoimenov et al., 2002). This has been 
demonstrated by Perelshtein et al., who successfully deposited 0.75 wt% of ZnO NPs (30 nm) 
onto the surface of bandage fabrics with excellent bactericidal efficacy (Perelshtein et al., 
2009).  
 
There is much evidence (detailed in section 1.2.3.2) showing that almost all of topically-
applied ZnO NPs remain on the skin surface and do not penetrate beyond the stratum 
corneum of healthy skin (Elder, et al., 2009;  Zvyagin, et al., 2008). However, if the skin is 
damaged, such as with sun burned skin or wounds, applying a ZnO NP-containing product on 
the skin may result in some penetration through the skin, with an unknown potential for harm. 
In these scenarios, ZnO NPs may penetrate into the stratum corneum and meet immune cells, 
which may treat NPs as foreign invaders and trigger immune responses.  
 
Besides the major function of being a natural barrier, the skin is also an important contributor 
to the immune system and its function. Almost half of the cell types in the skin are immune 
related, including keratinocytes, immature and mature dendritic cells (DCs), monocytes, 
macrophages, granulocytes, mast cells, T lymphocytes and their subpopulations, and vascular 
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and lymphatic endothelial cells (Bos et al., 2009). Of these, DCs are one of the most 
important skin immune cell types (detailed in section 1.3.2.3), and are professional antigen 
presenting cells (APCs) with the ability to internalize antigen, and then migrate to initiate 
specific immunity. 
 
Langerhans cells (LCs) are DCs that are usually found in the epidermal layer of the skin, and 
form a cellular network that surveys the epidermis for foreign invaders (Merad et al., 2008). 
Their location at the barrier surface provides these LCs with early access to skin pathogens 
and foreign chemicals, including NPs. If the skin is attacked by pathogens, LCs can transport 
their antigens to lymph nodes where they are presented to naïve T cells and initiate specific 
immune responses. Thus, as most of the ZnO NPs used for personal care products are applied 
on the skin surface, those ZnO NPs that actually penetrate the skin to reach viable cells would 
encounter LCs as the first immune cell type. If sufficient ZnO NPs penetrate the skin, they 
may potentially change the antigen presentation functions of these cells, so it is very 
important to investigate the effect of ZnO NPs on human LCs. 
 
Major histocompatibility complex (MHC) class I and II are important cell surface markers for 
APCs, and are responsible for the activation of T cells and initiation of immune responses. 
Changes in MHC expression can reflect potential changes in the antigen presentation 
functions of these cells. Kitamura et al. have shown that stimulation of DCs with the Toll-like 
receptor 4 agonist lipopolysaccharide (LPS) suppressed the expression of zinc transporters, 
which in turn decreased the intracellular free zinc levels in DCs while increasing their surface 
expression of MHC II (Kitamura et al., 2006).   
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As it is difficult to isolate primary LCs directly from skin, LCs are usually generated from 
peripheral blood mononuclear cells (CD14+ monocytes) or from blood- or bone marrow-
derived CD34+ hematopoietic progenitor cells (Romani et al., 1994;  Strobl et al., 1996). 
However, generating LCs from primary cells often faces obstacles, such as donor variability 
and scarcity of LC precursors. To obtain an unlimited and readily available source of LCs, in 
the present study we differentiated the CD34+ acute myelomonocytic leukemia cell line 
MUTZ-3 into LCs using in vitro stimulation with cytokines (Masterson, et al., 2002;  
Santegoets, et al., 2006). 
 
As NPs may have the potential to cause allergic responses or immune suppression, it is 
important to assess the antigen presentation capacity of immune cells affected by NPs. In this 
study, we investigated the antigen processing and presentation of ZnO NP-exposed 
monocytes and LCs, as well as the response of adaptive elements of immunity caused by 
these changes. The cytokine profiles of ZnO NP-exposed monocytes and LCs were also 
examined in this study. We have shown that ZnO NPs cause simultaneous pro-inflammatory 
and anti-inflammatory effects in antigen presenting cells. 
 
 
5.2 Materials and methods 
5.2.1 Materials  
ZnO NPs with primary particle diameters of 30 and 200 nm, with and without surfactant 
dispersant were used in this study. Full physical characterization methods and results for  
these materials are described in section 2.1 and 3.3.1. 
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5.2.2 Cell culture and in vitro test system.  
MUTZ-3 monocytes and LCs were used in this study. MUTZ-3 LCs are differentiated from 
MUTZ-3 monocytes by stimulation with cytokines for 9 days, and the details of the cell 
culture and differentiation methods are described in section 2.3.3. The particle preparation for 
addition to the test system and the cytotoxicity assay are described in sections 2.2 and 2.4, 
respectively. 
 
5.2.3 MHC I and II expression  
MHC I and II expression were measured on MUTZ-3 monocytes and MUTZ-3 derived LCs 
incubated with NPs for 24 hr, using specific MHC I and II antibodies (HLA-ABC and HLA-
DR from BD Pharmingen, San Diego, CA, USA). Cells were seeded in 96-well plates and 
incubated with ZnO NPs for 24 hr as described above for the cell culture procedure. After 24 
hr of co-culture with NPs, cells were washed with PBS, and then incubated with MHC I and 
II antibodies for 30 min in a dark and humidified incubator at 37°C and 5% CO2. The cells 
were then washed again with PBS to remove unattached antibodies. Finally, fresh media was 
added and cells were analyzed using flow cytometry. Each treatment was performed in 
triplicate for each of two experiments. 
 
5.2.4 Lymphocyte Proliferation Assay 
The human acute monocytic leukemia cell line (THP-1) was cultured following the protocol 
as previously described in section 2.3.1. Macrophages were differentiated from THP-1 
monocytes by incubating 8×10
4
 cells per well with 20 nM phorbol-12-myristate-13-acetate 
(PMA) for 24 hr. After which, the media was aspirated off and fresh media containing NPs at 
a concentration of 10 and 50 µg/mL was added. 24 hr later, NP-exposed THP-1 macrophages 
were washed 3 times in cell culture media to remove extracellular NPs. Then these pre-
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exposed macrophages are examined for their ability to stimulate proliferation of blood 
lymphocytes. The isolation procedure for blood lymphocytes is described in section 2.3.2. 
Blood lymphocytes were incubated with THP-1 macrophages using cell number ratio of 
100:1. After 7 days of incubation, cell proliferation was examined by the MTS assay 
according to section 2.4.2. Each treatment was performed in triplicate. 
 
5.2.5 Cytokine profiling 
After exposure of cells with NPs for 20 hr, 100 µL of cell supernatant was removed and 
frozen at -80°C for cytokine analysis. Human IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-9, IL-
10, IL-12 p70, IL-13, IL-17A, IL-22 and TNF-α were measured on thawed cell supernatants 
via flow cytometry using a Human Th1/Th2/Th9/Th17/Th22 13plex FlowCytomix Multiplex 
kit (eBioscience, San Diego, CA, USA). In this kit multi-beads are designed with two 
different sizes and spectral coating with antibodies specifically to different cytokines. To set 
up the assay for the flow cytometer, two sets of beads are gated based on their size. Each set 
of beads consists of several bead populations internally dyed with different intensities of a 
fluorescent dye. In this kit the two different bead sizes make it possible to distinguish up to 
20 bead sets in one fluorescence channel. Although 13 cytokines were simultaneously 
analysed in the samples for this project, a maximum of 20 different bead sets distinguished by 
internal dye intensity and bead size allow the simultaneous quantification of 20 analytes in a 
single small volume sample. In this study, enzyme linked immunosorbant assay (ELISA) was 
also used to specifically measure IL-8 on thawed cell supernatants. Each treatment was 
performed in triplicate for each of two to three experiments. 
 
 
 120 
 
5.3 Results  
5.3.1 Cytotoxicity profiling  
In this study, we initially investigated the cytotoxicity of ZnO NPs on human LCs. Pristine 
and surfactant-coated ZnO NPs with a diameter of 30 nm were examined as the test NPs. 
ZnO particulate with a diameter of 200 nm was employed as the bulk material control. As 
zinc ions are an important factor in the cytotoxicity of ZnO, we also employed ZnCl2 as the 
zinc ion control.  
 
The LCs were successfully differentiated from MUTZ-3 monocytes after 9 days of in vitro 
stimulation with GM-CSF, TNF-α and TGF-β1 (see section 2.3.3). In this study, both MUTZ-
3 monocytes and LCs were exposed with NPs for direct comparison. After 24 hr of exposure 
to ZnO NPs, we can see that MUTZ-3 LCs are >2-fold more sensitive to ZnO NPs than 
MUTZ-3 monocytes (Figure 5.1). That is, MUTZ-3 LCs exhibited an EC50 of ~50 µg/mL, 
while the EC50 for MUTZ-3 monocytes was >100 µg/mL. In addition, surfactant-dispersed 
ZnO 30 was more cytotoxic to both cell types than the pristine ZnO NPs, but had a similar 
cytotoxicity profile to ZnCl2.  
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Figure 5.1 Cell viability of human MUTZ-3 monocytes (A) and Langerhans cells (B) after 24 
hr exposure to pristine or surfactant-dispersed (s) ZnO NPs, or ZnCl2 (zinc ion control) (mean 
± SEM, n=3 experiments). 
 
5.3.2 MHC I and II expression  
In this study, we employed specific monoclonal antibodies for MHC I and II to investigate 
the antigen processing and presentation of immune cells after exposure of ZnO NPs. After 24 
hr exposure to ZnO particulates or ZnCl2, the MHC I expression in both MUTZ-3 monocytes 
and LCs was suppressed in a dose-dependent manner (Figure 5.2). We also observed a 
similar dose-dependent reduction in the MHC II expression profile (Figure 5.3), as was seen 
with MHC I. 
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Figure 5.2 MHC I expression of human MUTZ-3 monocytes (A) and Langerhans cells (B) 
after 24 hr exposure to pristine or surfactant-dispersed (s) ZnO NPs or ZnCl2 (zinc ion control) 
(mean ± SEM, n=2 experiments). Concentrations marked with stars were significantly 
different from untreated control cells (* p<0.05, ** p < 0.01, *** p<0.001). 
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Figure 5.3 MHC II expression of human MUTZ-3 monocytes (A) and Langerhans cells (B) 
after 24 hr exposure to pristine or surfactant dispersed (s) ZnO NPs or ZnCl2 (zinc ion control) 
(mean ± SEM, n=2 experiments). Concentrations marked with stars were significantly 
different from untreated control cells (* p<0.05, ** p < 0.01, *** p<0.001). 
 
5.3.3 Lymphocyte Proliferation Assay  
In this study, we have developed a lymphocyte proliferation assay, in which THP-1 
macrophages pre-exposed to ZnO NPs were examined for their ability to stimulate 
proliferation of blood lymphocytes. Preliminary data from these experiments has shown the 
potential for zinc to cause a dose-dependent stimulation of immune proliferation, measured as 
an increased metabolic conversion of MTS (Figure 5.4). 
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Figure 5.4 Lymphocyte proliferative response induced from THP-1 macrophages exposed to 
ZnO NPs. Both sub-toxic and cytotoxic concentrations of ZnO NPs were able to elicit a 
lymphocyte response (mean ± SEM, n=3 replicates). Concentrations marked with stars were 
significantly different from untreated control cells (* p<0.05, ** p < 0.01). 
 
5.3.4 Cytokine profiling 
In this study, we also examined the cytokine profiles of ZnO NP-exposed MUTZ-3 
monocytes and LCs. We employed a fluorescent bead-based high-throughput multiplex kit 
and screened 13 different inflammatory cytokines by flow cytometry. The cytokines 
measured included: Th1 characteristic cytokines, IL-12 p70, IFN-γ, and IL-2; Th2 
characteristic cytokines, IL-4, IL-5, IL-6, IL-10 and IL-13; Th9-related pro inflammatory 
cytokine, IL-9; Th17-related pro-inflammatory cytokine, IL-17A; Th22-related pro-
inflammatory cytokine, IL-22; and pro-inflammatory cytokines IL-1β and TNF-α. Cells were 
exposed to ZnO NPs or ZnCl2 at two concentrations, i.e. the sub-toxic dose of 10 µg/mL 
(Figure 5.5) and the higher dose of 50 µg/mL (Figure 5.6), which approximated the 
cytotoxicity EC50 value of sZnO 30 NPs in the LCs. We can see from these cytokine profiles 
that the various zinc-related exposures had different effects on the cytokines investigated. 
The expression of some cytokines was suppressed, while other cytokines were stimulated. 
For example, the Th1 cytokine IL-2 expression was suppressed in LCs exposed to ZnO NPs 
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(both 10 and 50 µg/mL), while, the Th2 cytokine IL-13 is stimulated in ZnO NP-exposed 
LCs.  
 
 
Figure 5.5 Multiplex cytokine profile of MUTZ-3 monocytes (A) and LCs (B) after 20 hr 
exposure to 10 µg/mL ZnO 30 nm surfactant-dispersed (sZnO) nanoparticles, ZnO 200 or 
zinc chloride (ZnCl2) (mean ± SEM, n=3 replicates). 
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Figure 5.6 Multiplex cytokine profile of MUTZ-3 monocytes (A) and LCs (B) after 20 hr 
exposure to 50 µg/mL ZnO 30 nm surfactant-dispersed (sZnO) nanoparticles, ZnO 200 or 
zinc chloride (ZnCl2) (mean ± SEM, n=3 replicates). 
 
In this study, we also employed the ELISA method to examine IL-8 release in more detail, as 
this method is more precise in quantitating individual cytokine levels than the multiplex assay. 
We observed that at the sub-toxic dose, IL-8 expression increased with increasing ZnO dose, 
while at toxic doses the IL-8 expression was decreased due to the low viable cell number 
(Figure 5.7). It should be noted that sub-toxic and toxic doses were different between the 
particles and cell lines. ZnO 30 and ZnO 200 are sub-toxic in both monocytes and LCs over 
the whole dose range we used in this study. However, for monocytes the sZnO 30 and ZnCl2 
treatments were sub-toxic at 10 and 50 µg/mL, and cytotoxic at 100 µg/mL. Whereas, for 
LCs the sZnO 30 and ZnCl2 treatments were only sub-toxic at 10 µg/mL, but were cytotoxic 
at 50 and 100 µg/mL. 
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Figure 5.7 IL-8 expression of human MUTZ-3 monocytes (A) and Langerhans cells (B) after 
24 hr exposure to pristine or surfactant-dispersed (s) ZnO NPs or ZnCl2 (zinc ion control) 
(mean ± SEM, n=3 experiments). Concentrations marked with stars were significantly 
different from untreated control cells (* p<0.05, ** p < 0.01, *** p<0.001). 
 
5.4 Discussion 
ZnO NPs are widely formulated as UV filters in sunscreens, but the effects of ZnO NPs on 
the function of cellular elements of the innate immune system are not well characterised. LCs 
are the only dendritic cells of the epidermis and constitute the first immunological barrier 
against NPs (Merad, et al., 2008). In this study, we investigated the effect of ZnO NPs on the 
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function of MUTZ-3 derived LCs. We used this system to assess whether the antigen 
presentation of these cells has been affected by ZnO NP exposure.  
 
In this preliminary study, we investigated the cytotoxicity profile of ZnO NPs on human LCs. 
We found that the cytotoxicity profile data in the LC exposure system (Figure 5.1) was very 
similar to that seen in the THP-1 cell exposure system (Figure 3.5). That is, surfactant-
dispersed ZnO 30 is more cytotoxic than pristine ZnO 30. The main difference from the THP-
1 cell exposure system is that the cytotoxicity of ZnO 30 in this MUTZ-3 cell exposure 
system is very similar to that of ZnO bulk particulate. This suggests that even for the same 
NP, the cytotoxicity profile can be different between immune cell types and exposure systems. 
These different cytotoxicity profiles generated from different cell lines make it difficult for 
interpreting, and extrapolating from, in vitro exposure studies. From the cytotoxicity data we 
also found that the ZnCl2 control was more cytotoxic to LCs than pristine ZnO NPs and bulk 
ZnO. As has been suggested by many studies that Zn
2+
 is related to the cytotoxicity of ZnO 
NPs (Muller et al., 2010;  Sasidharan et al., 2011;  Xia et al., 2011), the findings here also 
suggest that zinc ions may be the main contributor for the cytotoxicity of ZnO particulates. 
 
Antigen processing and presentation of immune cells is very important to the body. If cells 
are attacked by intracellular pathogens, the surface proteins on the pathogen released into the 
cytosol would stimulate the production of MHC I. In this study, we have observed 
suppression of MHC I expression after 24 hr exposure of MUTZ-3 monocytes and LCs to 
ZnO or ZnCl2 (Figure 5.2). This result demonstrates that the cells do not respond to ZnO NPs 
as if they are antigens. It should be noted that in this in vitro exposure system, NPs are 
incubated in media with FBS, which can adsorb onto the particles and form the “protein 
corona” (Deng et al., 2009;  Lundqvist, et al., 2008), which could potentially cause the NPs 
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to interact with other proteins and receptors on the surface of cells. In addition, the 
dissolution of ZnO NP will happen intracellularly (Turney, et al., 2012), and zinc ions 
released from ZnO dissolution will complex with many intracellular proteins. Whilst this zinc 
ion binding to proteins could potentially alter some protein-ligand binding or enzyme 
functions, which could possibly mimic intracellular antigen release by a virus, the data 
suggests that this is not the case for these NPs. On the contrary, the observed down-regulation 
of MHC I suggested a level of immunosuppression, attributable to zinc ion interaction with 
intracellular components, which may indicate that high levels of intracellular zinc, if 
sustained, could suppress MHC I and create a potential vulnerability to viruses or tumours. 
 
At 50 µg/mL there was substantial reduction in monocyte MHC I expression without a loss of 
cell viability (Figure 5.1). This suggests that the cell viability cannot entirely explain this 
drop of MHC I expression. The suppression of MHC I may instead relate to the up-regulation 
of metallothionein (MT). It has been reported that MT can reduce the expression of MHC I in 
lymphocytes (Youn et al., 1999). It has been reported that ZnO NPs can significantly induce 
MT expression levels (Hanagata et al., 2010), which then cause suppression of MHC I. 
 
The MHC II expression data exhibited a very similar profile to MHC I. As the ZnO NP dose 
increased, the MHC II expression decreased. These data indicate that zinc particles have 
immunosuppressive properties. Also, both bulk and nanoparticulate forms of ZnO suppressed 
MHC levels, which suggests that the observed effects were due to zinc ion release, rather 
than any specific properties of zinc-containing nanomaterials. MHC II is presented on the cell 
surface after antigen processing by phagocytosis, and results in presentation of antigen 
fragments to T-cells and the initiation of an immune response. In our in vitro cell exposure 
system the LCs represent typical antigen presenting cells in the skin epidermis. The 
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suppression of the MHC II expression by ZnO particles could indicate that exposed LCs 
would not stimulate the T-cells to initiate an immune response. However, we observed a 
different phenomenon in the lymphocyte proliferation system. This multi-cellular indirect 
stimulation approach is more similar to the in vivo exposure scenario, in which exposed 
antigen-presenting cells travel to local lymph nodes, where they could potentially stimulate 
the production of lymphocytes and therefore generate an inflammatory response. In this 
preliminary study, we have shown that ZnO NPs can stimulate cell proliferation in primary 
human T cells. Altogether, these data indicate that ZnO NPs can simultaneously cause some 
pro-inflammatory and anti-inflammatory effects, which is consistent with our previous 
findings (Feltis, et al., 2012). It should also be noted that zinc is used clinically as a mild anti-
inflammatory – it might be that this simultaneous stimulation prevents it from having 
stronger anti-inflammatory properties. 
 
To investigate the cytokine profile following in vitro ZnO NP exposure, we employed a 
multiplex cytokine assay. We have demonstrated that ZnO NPs can simultaneously cause 
pro-inflammatory effects from the cytokine profile, in contrast to the anti-inflammatory 
effects. It has been reported that Interleukin-8 (IL-8) is associated with zinc exposure and 
bacterial infection (Hirao et al., 2000;  Kim et al., 2006). After detecting elevated IL-8 in NP-
exposed macrophages, we employed the ELISA method to examine IL-8 in more detail, as it 
is more sensitive than the multiplex assay. We observed that at sub-toxic doses, IL-8 
expression increased with increasing ZnO dose, while at cytotoxic concentrations the IL-8 
expression was decreased, due to the low number of viable cells (Figure 5.7). From the ZnO 
NP cytotoxicity data (Figure 5.1), we can see that ZnO 30 and 200 NPs are not that toxic 
compared with sZnO NPs and ZnCl2. At a dose of 100 µg/mL, ZnO 30 and 200 NP-treated 
cells still had cell viabilities around 80% of the control incubation. This is why we can still 
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see the increased IL-8 expression for ZnO 30 and 200 NPs at the highest dose (Figure 5.7). 
While, for sZnO 30 and ZnCl2, the reduced cell viability at the highest dose results in only a 
small viable cell population to contribute to cytokine production, thus we see that IL-8 
expression decreased for sZnO 30 and ZnCl2 at this high dose (Figure 5.7). 
 
In summary of the third part of this project, the effect of ZnO NPs on the function of LCs was 
investigated, as these dendritic cells are present in the epidermis and constitute the first 
immunological barrier against NPs. We found that ZnO NPs can simultaneously cause pro-
inflammatory effects (as increased IL-8 and lymphocyte proliferation) and anti-inflammatory 
effects (as decreased MHC I and II expression in these antigen presenting cells). This study 
indicates that ZnO NPs may modulate antigen presentation processes, which could help to 
explain its anti-allergic properties. 
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Chapter 6 General discussion and 
conclusions 
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6.1 General discussion 
Despite increasing use of new transparent sunscreens containing NPs of photoactive ZnO and 
TiO2, the effect of these nanomaterials on innate immunity was previously unknown. This is 
particularly important as tissue resident immune cells are a first point of contact where NPs 
can be actively sequestered by cells. The aim of this project was to investigate the 
interactions between human immune cells and sunscreen NPs in an in vitro exposure system. 
In this project, the NP treatment doses used were likely to be higher than would be expected 
for topical exposure, as there is negligible penetration of NPs through human skin. These 
relatively higher doses amplify the effects of NPs in the in vitro exposure system, and enable 
us to see the differences in cellular responses between the NP treatments of different size and 
surface coating. Although the NP exposure dose in my project is higher than for topical 
exposure, this may not necessarily be the case for high levels of inhalational exposure, where 
respiratory immune cells like macrophages and DCs may encounter high direct amounts of 
NPs. Therefore, the findings of my project are also relevant to other exposure routes. 
 
Generally, ZnO NPs are more directly cytotoxic than TiO2 NPs, which is mainly due to the 
dissolution properties of ZnO in certain biological conditions. The relationships between the 
cytotoxicity of ZnO NPs, intracellular Zn
2+
 level and ROS production were addressed and 
quantified in this project. In addition, extracellular dissolution of ZnO NPs in cell culture 
media has been shown not to be sufficient to cause cytotoxicity, indicating a lack of soluble 
bioavailable zinc within the cell culture environment. Most of the Zn
2+
 released 
extracellularly from ZnO NPs interacted with PO4
3-
 or CO3
2-
 in the cell culture media to form 
zinc salt precipitates (Turney, et al., 2012). In a related study by Xu and coworkers, the ZnO 
NPs were removed from the supernatant by high speed centrifugation (Xu et al., 2013). They 
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then compared the cytotoxicity of the supernatant (containing zinc ions released from ZnO 
NP dissolution) with a ZnO NP suspension in a human A549 lung epithelial cell exposure 
system. These investigators estimated that the toxic contribution of extracellular zinc ions to 
the A549 cell lines was only about 10%. Although this contribution was greater than that seen 
in this project, it is likely due to methodological differences (where NPs spend a longer 
period in the supernatant liquid during the centrifugation step), and is consistent overall with 
the findings of my project. Therefore, the soluble extracellular [Zn
2+
] released from ZnO NPs 
in the cell culture environment is not toxic to the cells. Whilst intracellular ROS is strongly 
related to cytotoxicity, it can also be modulated by antioxidant treatment without altering the 
cell viability – suggesting the standing premise that “ROS induces cytotoxicity” may be an 
oversimplification of a more complex series of events. Organelles like mitochondria also leak 
electrons and are a major source of intracellular ROS. Other possible sources of 
mitochondrial ROS may occur indirectly, e.g. generated by zinc ions fully occupying the 
divalent metal ion binding sites of oxidative stress defense macromolecules, such as 
metallothionein. When excessive zinc ion levels released from ZnO NP bind with these 
proteins, they could compete with, and displace, other transition metal ions, such as Fe and 
Cu, that would then be freely available to catalyze Fenton-type reactions and generate ROS. 
 
The relatively low cytotoxicity of zinc and its intracellular dissolution could find application 
in therapeutic drug delivery. It has been reported recently that NPs can be engineered to 
deliver drugs to specific sites of inflammation using biocompatible polymers that degrade in 
the presence of peroxide (de Gracia Lux et al., 2012). It follows that a ZnO nanoshell could 
be designed to only deliver its core payload after endocytosis, when the localized pH in 
endosomes was sufficiently acidic to dissolve ZnO. By extension, other NPs could be 
engineered to degrade at very specific points along the endocytic or phagocytic pathways. 
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While there is a promising future for the application of NPs in medical therapy, their safety 
must be considered first, and a mechanistic understanding of how these materials interact 
with living cells will greatly assist this process. 
 
One important aim of this study was to attempt to understand the possible mechanism of 
sunscreen NP effects on human immune cells and develop more effective, less allergenic 
sunscreen NPs. The currently understood paradigm for ZnO NP cytotoxicity is that in human 
immune cells, ZnO NPs first undergo endocytosis to enter the cells, then dissolve into 
bioavailable zinc and increase oxidative stress, which then causes cytotoxicity. Based on this 
mechanism, we modified the surface of ZnO NP with PEG coating and successfully reduced 
the cytotoxicity of ZnO NPs. It has been reported that PEGylation of NPs is very effective in 
inhibiting their nonspecific binding to blood proteins and macrophages (Karakoti et al., 2011). 
In this study, uptake of PEGylated ZnO NPs was significantly reduced, which mainly 
contributed to the reduced cytotoxicity of ZnO NPs. This preliminary study provides us a 
new strategy in the safety-by-design approach to develop safer ZnO NPs in the future. 
 
As ZnO and TiO2 NPs are widely formulated in sunscreens, in this project we also 
investigated the effects of these metal oxide NPs on human immune cells in the presence of 
UVA. Although some ROS generation occurs in cells exposed to ZnO and TiO2 NPs in the 
absence of UV light (Shen, et al., 2013), it is unknown to what extent this ROS generation is 
altered with UVA co-exposure, which is more relevant to actual sunscreen usage. In order to 
determine the relative hazard potential of UVA co-exposure with nanosunscreen NPs, ROS 
generation was investigated in human THP-1 monocyte immune cells co-exposed to UVA 
and ZnO or TiO2 NPs. This study confirmed that ROS generation from nanosunscreens, such 
as ZnO and rutile TiO2 NPs, does not contribute significantly to the overall hazard associated 
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with oxidative stress from UVA exposure itself. Therefore, excessive UV light is a well-
known and greater risk for skin damage and cancer compared to a perceived risk from using 
nanosunscreen that is not supported by our findings or the scientific literature. It is crucial 
that people do not stop using the most effective broad spectrum sunscreens as part of their 
sun protection measures. It should also be noted that ROS generated by UVA alone did not 
cause cytotoxicity in this test system. In contrast, many literature reports have suggested that 
ZnO NPs are supposed to cause cytotoxicity by generating ROS (Hanley et al., 2009; Lin et 
al., 2009; Xia, et al., 2008). These two points are contradictory, but in this project, I have 
shown that antioxidants can modulate ROS production by ZnO NPs, without altering the 
resultant cell viability. This suggests that ROS may not be the main cause for the cytotoxicity 
of ZnO NPs. 
 
In this project, the effects of ZnO NPs on antigen processing and presentation were also 
investigated. LCs were employed as a typical and relevant APC type for this study. LCs are 
usually found in the epidermal layer of the skin, and form a cellular network that surveys the 
epidermis for foreign invaders. If ZnO NPs penetrated the skin sufficiently to reach viable 
cells, the first immune cells they would encounter are LCs, and could therefore potentially 
alter the antigen presentation functions of these cells. In this project, we have shown that 
MHC I & II expression are suppressed by ZnO NP exposure. However, we have also seen 
that ZnO NPs have potential to stimulate immune cell proliferation in a multi-cellular indirect 
stimulation approach. We have also examined the release of bioactive molecules by screening 
for alterations in cytokine profiles following ZnO NP exposure. It was shown that the 
expression of some cytokines was suppressed, while others were stimulated. These findings 
indicate that ZnO NPs can simultaneously cause pro-inflammatory and anti-inflammatory 
effects in these antigen presenting cells.  
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6.2 Conclusions 
In conclusion, sunscreen ZnO and TiO2 NPs are well tolerated by skin immune cells, with 
only ZnO causing cytotoxicity at very high concentrations. Also, ZnO NPs possess 
immunomodulatory effects that provide further evidence of the mode of action in the 
therapeutic topical use of zinc. 
 
We have demonstrated that the intracellular dissolution of ZnO NPs, with subsequent release 
of bioavailable Zn,
 
is the main determinant of cytotoxicity for ZnO NPs. Moreover, these 
factors both correlate strongly with each other and with intracellular reactive oxygen 
generation, providing strong evidence that both of these determinants are required for ZnO 
NP cytotoxicity in human immune cells. Whilst dissolution of ZnO NPs may occur to some 
extent extracellularly, the extracellular concentration of bioavailable Zn
 
released from ZnO 
NPs is insufficient to induce cytotoxicity, even with extremely high starting concentrations of 
NPs. Adding further complexity, intracellular superoxide levels can be slightly reduced 
without altering cytotoxicity, suggesting that part of the mitochondrial superoxide signal is 
likely to be the result of intracellular damage, and therefore ROS is not the sole cause of ZnO 
NP-induced cytotoxicity in this test system. 
 
In this project, we also investigated intracellular peroxide and mitochondrial superoxide 
generation of sunscreen NP-exposed THP-1 monocytes in the presence and absence of UVA. 
These cells, as accumulators of particulates in body fluids and tissues, would be expected to 
have higher levels of NP exposure and thus should be the primary focus for ROS induced by 
UVA and NP co-exposure in the skin. We demonstrated that, with the exception of anatase 
TiO2, ROS generation in these human immune cells following sunscreen NP and UVA co-
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exposure is less than or equal to cellular ROS produced by UVA alone. The implications of 
this observation are that, whilst chemically it may be possible to demonstrate significant ROS 
activity in these materials over extended periods of UV exposure (such as with painted metal 
surfaces), at a biological level the quantity of ROS these NPs produce even in the presence of 
UV is insignificant compared with normal environmental stimuli (i.e. UV light itself). For 
sunscreen formulations, photocatalytic ROS generation induced by ZnO NPs and TiO2 NPs 
of low anatase content appear to be of very low toxicological concern. 
 
In this project, we also investigated effect of ZnO NPs on the antigen processing and 
presentation of MUTZ-3 monocytes and LCs. This range of responses suggests that ZnO NPs 
can cause simultaneous pro-inflammatory and anti-inflammatory effects in antigen presenting 
cells. This study indicates that ZnO NPs may modulate antigen presentation processes that 
can lead to allergic reactions. 
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6.3 Future directions 
Preliminary work was performed in this project to modulate the cytotoxicity of ZnO NPs by 
surface modification with PEG coating. The uptake of PEGylated ZnO NPs was investigated 
by measuring the total cell-associated zinc using ICP-MS. In future work, the effects of 
different coatings on particle uptake and dissolution should be investigated. One may also 
examine why such coatings don’t affect some aspects of NP bioactivity. All of these studies 
would help us gain a better understanding of the cellular responses of immune cells exposed 
to sunscreen metal-oxide NPs that will help in the safety evaluation of these products, as well 
as in the safety-by-design approach to developing more effective, hypoallergenic sunscreen 
NPs. 
 
In the epidermis layer, keratinocytes constitute more than 90% of epidermal cells, while LCs 
represent 3-5% of epidermal cells. It should be noted that although LCs only constitute a 
small percentage of epidermal cells, these cells still account for the majority of immune cells 
in the epidermis layer. Therefore, co-culture of keratinocyte and LCs in an in vitro exposure 
system may be used to better mimic the in vivo responses of the epidermis. Thus, future 
research could involve exposing this in vitro co-culture system to NPs and UVA or UVB, 
further reproducing a more in vivo-like scenario. Also raising cells the cultured keratinocyte 
cell layer to an air interface to allow the formation of a keratinised layer would more easily 
enable the testing of sunscreen formulations, applied to the uppermost surface. 
 
Finally, as we investigated the antigen processing and presentation of ZnO NP-exposed 
MUTZ-3 monocytes and LCs, primarily through changes in MHC I & II expression, future 
studies could examine whether ZnO NPs affect the presentation of viral, bacterial and tumour 
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antigens. One may also use the in vitro exposure methodologies developed in this project to 
study the effects of ZnO NPs on tumour surveillance by immune effector cells, such as 
natural killer cells and cytotoxic T lymphocytes. 
 
In this project, we have obtained important information on the cellular responses of innate 
immune cells exposed to sunscreen NPs. To extend and validate the findings further, it would 
be desirable to investigate the effect of these NPs in an animal model. 
 
Consequently, this project has provided an important foundation from which to conduct 
future mechanistic investigations and screening assays of the skin effects of metal oxide NPs 
used in sunscreens and industry. 
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